<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Genome Biol</journal-id>
    <journal-id journal-id-type="iso-abbrev">Genome Biol</journal-id>
    <journal-title-group>
      <journal-title>Genome Biology</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1474-7596</issn>
    <issn pub-type="epub">1474-760X</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7007693</article-id>
    <article-id pub-id-type="publisher-id">1934</article-id>
    <article-id pub-id-type="doi">10.1186/s13059-020-1934-6</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Method</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Lisa: inferring transcriptional regulators through integrative modeling of public chromatin accessibility and ChIP-seq data</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Qin</surname>
          <given-names>Qian</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Fan</surname>
          <given-names>Jingyu</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zheng</surname>
          <given-names>Rongbin</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wan</surname>
          <given-names>Changxin</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Mei</surname>
          <given-names>Shenglin</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wu</surname>
          <given-names>Qiu</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Sun</surname>
          <given-names>Hanfei</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Brown</surname>
          <given-names>Myles</given-names>
        </name>
        <xref ref-type="aff" rid="Aff5">5</xref>
        <xref ref-type="aff" rid="Aff6">6</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Zhang</surname>
          <given-names>Jing</given-names>
        </name>
        <address>
          <email>zhangjing@tongji.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8321-2839</contrib-id>
        <name>
          <surname>Meyer</surname>
          <given-names>Clifford A.</given-names>
        </name>
        <address>
          <email>cliff_meyer@ds.dfci.harvard.edu</email>
        </address>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff6">6</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Liu</surname>
          <given-names>X. Shirley</given-names>
        </name>
        <address>
          <email>xsliu@ds.dfci.harvard.edu</email>
        </address>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff6">6</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.24516.34</institution-id><institution-id institution-id-type="ISNI">0000000123704535</institution-id><institution>Clinical Translational Research Center, Shanghai Pulmonary Hospital, School of Life Science and Technology, </institution><institution>Tongji University, </institution></institution-wrap>Shanghai, 200433 China </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.411333.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 0407 2968</institution-id><institution>Center of Molecular Medicine, </institution><institution>Children’s Hospital of Fudan University, </institution></institution-wrap>Shanghai, 201102 China </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.24516.34</institution-id><institution-id institution-id-type="ISNI">0000000123704535</institution-id><institution>Stem Cell Translational Research Center, Tongji Hospital, School of Life Science and Technology, </institution><institution>Tongji University, </institution></institution-wrap>Shanghai, 200065 China </aff>
      <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.65499.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 2106 9910</institution-id><institution>Center for Functional Cancer Epigenetics, </institution><institution>Dana-Farber Cancer Institute, </institution></institution-wrap>Boston, MA 02215 USA </aff>
      <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Department of Medical Oncology, Dana-Farber Cancer Institute, </institution><institution>Harvard Medical School, </institution></institution-wrap>Boston, MA 02215 USA </aff>
      <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Department of Data Sciences, </institution><institution>Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health, </institution></institution-wrap>Boston, MA 02215 USA </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>7</day>
      <month>2</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>7</day>
      <month>2</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2020</year>
    </pub-date>
    <volume>21</volume>
    <elocation-id>32</elocation-id>
    <history>
      <date date-type="received">
        <day>5</day>
        <month>6</month>
        <year>2019</year>
      </date>
      <date date-type="accepted">
        <day>13</day>
        <month>1</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s). 2020</copyright-statement>
      <license license-type="OpenAccess">
        <license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <p id="Par1">We developed Lisa (<ext-link ext-link-type="uri" xlink:href="http://lisa.cistrome.org/">http://lisa.cistrome.org/</ext-link>) to predict the transcriptional regulators (TRs) of differentially expressed or co-expressed gene sets. Based on the input gene sets, Lisa first uses histone mark ChIP-seq and chromatin accessibility profiles to construct a chromatin model related to the regulation of these genes. Using TR ChIP-seq peaks or imputed TR binding sites, Lisa probes the chromatin models using in silico deletion to find the most relevant TRs. Applied to gene sets derived from targeted TF perturbation experiments, Lisa boosted the performance of imputed TR cistromes and outperformed alternative methods in identifying the perturbed TRs.</p>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Transcription factors</kwd>
      <kwd>Gene regulation</kwd>
      <kwd>Chromatin accessibility</kwd>
      <kwd>DNase-seq</kwd>
      <kwd>H3K27ac ChIP-seq</kwd>
      <kwd>Differential gene expression</kwd>
      <kwd>Gene set analysis</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id>
            <institution>National Cancer Institute</institution>
          </institution-wrap>
        </funding-source>
        <award-id>U24 CA237617</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id>
            <institution>National Institutes of Health</institution>
          </institution-wrap>
        </funding-source>
        <award-id>U24 HG009446</award-id>
        <principal-award-recipient>
          <name>
            <surname>Liu</surname>
            <given-names>X. Shirley</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Science and Technology Commission of Shanghai Municipality (CN)</institution>
        </funding-source>
        <award-id>18YF1402500</award-id>
        <principal-award-recipient>
          <name>
            <surname>Qin</surname>
            <given-names>Qian</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id>
            <institution>National Natural Science Foundation of China</institution>
          </institution-wrap>
        </funding-source>
        <award-id>31801110</award-id>
        <principal-award-recipient>
          <name>
            <surname>Mei</surname>
            <given-names>Shenglin</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2020</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Introduction</title>
    <p id="Par2">Transcriptional regulators (TRs), which include transcription factors (TFs) and chromatin regulators (CRs), play essential roles in controlling normal biological processes and are frequently implicated in disease [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR4">4</xref>]. The genomic landscape of TF binding sites and histone modifications collectively shape the transcriptional regulatory environments of genes [<xref ref-type="bibr" rid="CR5">5</xref>–<xref ref-type="bibr" rid="CR8">8</xref>]. ChIP-seq has been widely used to map the genome-wide set of <italic>cis</italic>-elements bound by <italic>trans</italic>-acting factors such as TFs and CRs, which we henceforth refer to as “cistromes” [<xref ref-type="bibr" rid="CR9">9</xref>]. There are approximately 1500 transcription factors in humans and mice [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>], regulating a wide variety of biological processes in constitutive or cell-type-specific manners, and tens of thousands of ChIP-seq and DNase-seq experiments have been performed in humans and mice. We previously developed the Cistrome Data Browser (DB) [<xref ref-type="bibr" rid="CR12">12</xref>], a collection of uniformly processed TF ChIP-seq (~ 11,000) and chromatin profiles (~ 12,000 histone mark ChIP-seq and DNase-seq) in humans and mice.</p>
    <p id="Par3">The question we address in this paper is how to effectively use these data to infer the TRs that regulate a query gene set derived from differential or correlated gene expression analyses in humans or mice. TR ChIP-seq data, when available, is the most accurate available data type representing TR binding. ChIP-seq data availability, in terms of covered TRs and cell types, even with large contributions from projects such as ENCODE [<xref ref-type="bibr" rid="CR13">13</xref>], is still sparse due to the limited availability of specific antibodies. Although advances have been made in TR cistrome mapping with the introduction of technologies such as CETCh-seq [<xref ref-type="bibr" rid="CR14">14</xref>] and CUT &amp; RUN [<xref ref-type="bibr" rid="CR15">15</xref>], the difficulties in acquiring TR ChIP-seq data for new factors limit the TR by cell type coverage of high-quality TR ChIP-seq data. Chromatin accessibility data, including DNase-seq [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>] and ATAC-seq [<xref ref-type="bibr" rid="CR18">18</xref>], is available for hundreds of cell types and provides maps of the regions in which TRs are likely to be bound in the represented cell types. The H3K27ac histone modification, associated with active enhancers and promoters of actively transcribed genes, has been widely profiled using ChIP-seq in many cell types [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. When TF ChIP-seq data is not available, TF binding motifs, used in combination with chromatin accessibility data or H3K27ac ChIP-seq data might be used to infer TF binding sites [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. Machine learning approaches that transfer models learned from TF ChIP-seq peaks, motifs, and DNase-seq data between cell types are promising ways of imputing TF cistromes, although imputation of TF binding sites on a large scale remains to be implemented [<xref ref-type="bibr" rid="CR22">22</xref>–<xref ref-type="bibr" rid="CR27">27</xref>]. Computationally imputed TF binding data is expected to represent TF binding sites less accurately than TF ChIP-seq experimental data, so we sought to develop a TR prediction method that could use imputed TF cistromes effectively, along with ChIP-seq-derived ones.</p>
    <p id="Par4">We previously developed MARGE to characterize the regulatory association between H3K27ac ChIP-seq and differential gene expression in terms of a regulatory potential (RP) model [<xref ref-type="bibr" rid="CR28">28</xref>]. The RP model provides a summary statistic of the <italic>cis</italic>-regulatory influence of the many <italic>cis</italic>-regulatory elements that might influence a gene’s transcription rate. MARGE builds a classifier based on H3K27ac ChIP-seq RPs from the Cistrome DB to discriminate the genes in a query differentially expressed gene set from a set of background genes. One of the functions of MARGE is to predict the <italic>cis</italic>-regulatory elements (i.e., genomic intervals) that regulate a gene set. BART [<xref ref-type="bibr" rid="CR29">29</xref>] extends MARGE, to predict the TRs that regulate the query gene set through an analysis of the predicted <italic>cis</italic>-regulatory elements. Here, we describe Lisa (epigenetic Landscape In Silico deletion Analysis and the second descendent of MARGE), a more accurate method of integrating H3K27ac ChIP-seq and DNase-seq with TR ChIP-seq or imputed TR binding sites to predict the TRs that regulate a query gene set. Unlike BART, Lisa does not carry out an enrichment analysis of the <italic>cis</italic>-regulatory elements predicted by MARGE. Instead, Lisa analyses the relationship between TR binding and the gene set using RP models and RP model perturbations. We assessed the performance of Lisa and other TR identification methods, BART [<xref ref-type="bibr" rid="CR29">29</xref>], i-cisTarget [<xref ref-type="bibr" rid="CR30">30</xref>], and Enrichr [<xref ref-type="bibr" rid="CR31">31</xref>], using differentially expressed gene sets derived from experiments in which the activities of specific TFs were perturbed by knockdown, knockout, overexpression, stimulation, or inhibition.</p>
  </sec>
  <sec id="Sec2">
    <title>Results and discussion</title>
    <sec id="Sec3">
      <title>Regulatory TR prediction based on Cistrome DB ChIP-seq peaks</title>
      <p id="Par5">High-quality TR ChIP-seq data, when available, accurately characterizes genome-wide TR binding sites, which can be used to infer the regulated genes in particular cell types. Estimating the effect of TR binding on gene expression is not trivial because: (1) there is no accurate map linking enhancers to the genes they regulate [<xref ref-type="bibr" rid="CR32">32</xref>]; (2) multiple enhancers can regulate the same gene [<xref ref-type="bibr" rid="CR33">33</xref>], and a single enhancer can regulate multiple genes [<xref ref-type="bibr" rid="CR34">34</xref>]; and (3) not all TR binding sites are functional enhancers [<xref ref-type="bibr" rid="CR19">19</xref>]. A model is therefore needed to quantify the likelihood of a gene being regulated by a TR cistrome. The “peak-RP” model [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>] is based on TR ChIP-seq peaks, serving as a proxy for TR binding sites, without the use of DNase-seq or H3K27ac ChIP-seq data. In the peak-RP model (Fig. <xref rid="Fig1" ref-type="fig">1</xref>a), the effect a TR binding site has on the expression of a gene is assumed to decay exponentially with the genomic distance between the TR binding site and the transcription start site (TSS), and the contribution of multiple binding sites is assumed to be additive [<xref ref-type="bibr" rid="CR36">36</xref>]. Accounting for the number of TR binding sites and for the distances of these sites from the TSS has been shown to be more accurate than alternative TR target assignment methods [<xref ref-type="bibr" rid="CR37">37</xref>]. While it is possible that enhancers could modulate each other in non-additive ways [<xref ref-type="bibr" rid="CR32">32</xref>], data on these types of behavior are too scarce to incorporate in a TR prediction model.
<fig id="Fig1"><label>Fig. 1</label><caption><p>Illustration of the Lisa framework. <bold>a</bold> The peak-RP score models the effect of TR binding sites on the regulation of a gene. TR binding sites are binary values, and peaks nearer to the gene’s TSS have a greater influence than ones further away. <bold>b</bold> The chrom-RP score summarizes the effect of the DNase-seq or H3K27ac chromatin environment on a gene. The chrom-RP score is based on a continuous rather than a binary signal quantification. <bold>c</bold> Overview of the Lisa framework. (1) H3K27ac ChIP-seq or DNase-seq data from the Cistrome DB is summarized using the chrom-RP score for each gene. (2) H3K27ac ChIP-seq or DNase-seq samples that can discriminate between the query gene set and the background gene set are selected, and the regression parameters define a chrom-RP model. (3) Each TR cistrome from the Cistrome DB is evaluated as a putative regulator of the query gene set through in silico deletion, which involves the elimination of H3K27ac ChIP-seq or DNase-seq signal at the binding sites of the putative regulator. (4) The chrom-RP model, based on in silico deletion signal, is compared to the model without deletion for each gene in the query and background gene sets. A <italic>p</italic> value is calculated using the Wilcoxon rank test comparison of the query and background ΔRPs. (5) The peak-RP based on TR ChIP-seq peaks is calculated for the putative regulatory cistrome, and the statistical significance of peak-RP distributions from the query and background gene sets is calculated. (6) <italic>p</italic> values from the H3K27ac ChIP-seq, DNase-seq, and peak-RP analysis are combined using the Cauchy combination test. TR cistromes are ranked based on the combined <italic>p</italic> value</p></caption><graphic xlink:href="13059_2020_1934_Fig1_HTML" id="MO1"/></fig></p>
      <p id="Par6">We use the peak-RP model to identify TFs that are likely regulators of a target gene set by searching for Cistrome DB [<xref ref-type="bibr" rid="CR12">12</xref>] cistromes that produce higher peak-RPs for the query gene set than for a set of background genes (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1, Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S1). Statistical significance is calculated using the one-sided Wilcoxon rank-sum test statistic comparing the peak-RPs for the query gene set with the background. The TRs with the most significant <italic>p</italic> values are considered to be the candidate regulators. Lisa uses TR ChIP-seq within the peak-RP model, along with the chromatin landscape models described below to infer the TRs of a gene set.</p>
    </sec>
    <sec id="Sec4">
      <title>Regulatory TR prediction using a chromatin landscape model</title>
      <p id="Par7">While TR ChIP-seq data provides accurate information about TR cistromes in specific cell types, the Cistrome DB TR by cell type coverage is skewed towards a few TRs, such as CTCF, which are represented in many cell types, and towards cell types such as K562 (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1b-c), in which many TRs have been characterized (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1d). H3K27ac ChIP-seq [<xref ref-type="bibr" rid="CR19">19</xref>] and DNase-seq [<xref ref-type="bibr" rid="CR16">16</xref>], available in a large number and variety of cell types, can be used to infer cell-type-specific regulatory regions. These types of data could enhance the use of TR ChIP-seq data as well as imputed TF binding data, which may not accurately represent TF binding sites in different cell contexts.</p>
      <p id="Par8">To boost the performance of TF ChIP-seq or imputed TF binding data in the identification of regulatory TRs, we developed Lisa chromatin landscape models, which use H3K27ac ChIP-seq and DNase-seq chromatin profiles (Fig. <xref rid="Fig1" ref-type="fig">1</xref>b, Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Table S2; see the “<xref rid="Sec12" ref-type="sec">Methods</xref>” section) to model the regulatory importance of different genomic loci. As differential gene expression experiments are not always carried out in parallel with chromatin profiling experiments, Lisa does not require the corresponding user-generated chromatin profiles but instead uses the DNase-seq and H3K27ac ChIP-seq data that is available in the Cistrome DB to help identify <italic>cis</italic>-regulatory elements controlling a differential expression gene set. To this end, Lisa models chromatin landscapes through chromatin RPs (chrom-RPs, Fig. <xref rid="Fig1" ref-type="fig">1</xref>b), which are defined in a similar way to the peak-RP with one small difference: genome-wide read signals instead of peak calls are used in the calculation of the chrom-RP [<xref ref-type="bibr" rid="CR28">28</xref>]. Changes in H3K27ac ChIP-seq and DNase-seq associated with cell state perturbations are often a matter of degree rather than switch-like; therefore, we base the chrom-RP on reads rather than peaks. The chrom-RP is pre-calculated for each gene (Fig. <xref rid="Fig1" ref-type="fig">1</xref>c (1)) and for each H3K27ac ChIP-seq/DNase-seq profile in the Cistrome DB (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1a, Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Table S2). These chrom-RPs quantify the <italic>cis</italic>-regulatory activities that influence each gene under cell-type-specific conditions.</p>
      <p id="Par9">Given the query gene set, Lisa identifies a small number of Cistrome DB DNase-seq and H3K27ac ChIP-seq samples that are informative about the regulation of these genes. Lisa does this by using the pre-calculated H3K27ac/DNase-seq chrom-RPs to discriminate between the query gene set and a background gene set. Using L1-regularized logistic regression, Lisa assigns a weight to each selected sample so that the weighted sum of the chrom-RPs on the genes best separates the query and the background gene sets (Fig. <xref rid="Fig1" ref-type="fig">1</xref>c (2)). This step is carried out separately for H3K27ac ChIP-seq and DNase-seq, yielding a chrom-RP model based on H3K27ac ChIP-seq and another model based on DNase-seq.</p>
      <p id="Par10">Next, by a process of in silico deletion (ISD), Lisa evaluates the effect deleting each TR cistrome has on the chromatin landscape model (Fig. <xref rid="Fig1" ref-type="fig">1</xref>c (3)). ISD of a TR cistrome involves setting DNase-seq or H3K27ac ChIP-seq chromatin signal to 0 in the 1-kb intervals containing the peaks in that cistrome and evaluating the effect on the predictions made by the chromatin landscape models. The difference of the model scores before ISD and after ISD quantifies the impact that the deleted TR cistrome is predicted to have on the query and background gene sets. Lisa does not make a prediction of <italic>cis</italic>-regulatory elements, the approach taken by MARGE and BART. Instead, Lisa probes the effects of deleting putative regulatory TR cistromes on the chrom-RP model. Whereas the chrom-RP integrates data over 200-kb intervals, the scale of individual <italic>cis</italic>-regulatory elements is of the order of 1 kb. The ISD approach mitigates the difficulties in transferring information contained in the chrom-RP model from the chrom-RP (200 kb) scale to the <italic>cis</italic>-regulatory element (1 kb) scale.</p>
      <p id="Par11">Finally, to prioritize the candidate TRs, Lisa compares the predicted effects on the query and background gene sets using the one-sided Wilcoxon rank-sum test (Fig. <xref rid="Fig1" ref-type="fig">1</xref>c (4)). A one-sided test is used because Lisa assumes that the in silico deletion of a true regulatory factor will decrease, not increase, the model’s ability to discriminate between query and background gene sets. To utilize the power of predictions based on H3K27ac-ChIP-seq and DNase-seq ISD models, and TF ChIP-seq peak-only models (Fig. <xref rid="Fig1" ref-type="fig">1</xref>c (5)), the results are combined using the Cauchy combination test [<xref ref-type="bibr" rid="CR38">38</xref>] (Fig. <xref rid="Fig1" ref-type="fig">1</xref>c (6)). Whereas MARGE [<xref ref-type="bibr" rid="CR28">28</xref>] predicts <italic>cis</italic>-regulatory elements (but does not analyze TRs), and BART [<xref ref-type="bibr" rid="CR29">29</xref>] carries out an enrichment analysis of predicted <italic>cis</italic>-elements to discover TRs, Lisa uses the chromatin landscape model in a different way. In combination with ChIP-seq-derived or computationally imputed TR binding, Lisa probes the effects of TRs on the chromatin RP models of query and background gene sets.</p>
    </sec>
    <sec id="Sec5">
      <title>Demonstration of chromatin landscape models in a GATA6 knockdown study</title>
      <p id="Par12">We demonstrate Lisa chromatin landscapes and in silico deletion using a query gene set defined as the downregulated genes in a GATA6 knockdown experiment in the KATO-III stomach cancer cell line [<xref ref-type="bibr" rid="CR39">39</xref>] (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Lisa identifies DNase-seq and H3K27ac ChIP-seq chromatin landscape models (Fig. <xref rid="Fig2" ref-type="fig">2</xref>a, Fig. <xref rid="Fig1" ref-type="fig">1</xref>c (2)), which include several gastro-intestinal samples (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S2b,d) whose chrom-RPs can discriminate between the query and background gene sets (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S2a, DNase-seq ROC AUC = 0.816, Additional file 1: Figure S2c, H3K27ac ROC AUC = 0.821). In silico deletion (Fig. <xref rid="Fig1" ref-type="fig">1</xref>c (3)) of GATA6 binding sites produces larger DNase-seq and H3K27ac <italic>∆</italic>RPs (DNase <italic>∆</italic>RP, 1.05; H3K27ac <italic>∆</italic>RPs, 0.25) for an example downregulated gene, <italic>LINC01133</italic> [<xref ref-type="bibr" rid="CR40">40</xref>], than for a background gene, <italic>ZC3H12A</italic> (DNase <italic>∆</italic>RP, 0.06; H3K27ac <italic>∆</italic>RP, 0.01) (Fig. <xref rid="Fig2" ref-type="fig">2</xref>b). In silico deletion of CTCF binding sites, in contrast, has a smaller effect on the chromatin landscapes surrounding <italic>LINC01133</italic> (DNase <italic>∆</italic>RP, 0.02; H3K27ac <italic>∆</italic>RP, 0.01), resulting in <italic>∆</italic>RPs that are more similar to the <italic>∆</italic>RPs for <italic>ZC3H12A</italic> (Fig. <xref rid="Fig2" ref-type="fig">2</xref>b) (DNase <italic>∆</italic>RP, 0.004; H3K27ac <italic>∆</italic>RP, 0.001). Statistical analysis is carried out comparing all the query gene <italic>∆</italic>RPs with all the background gene <italic>∆</italic>RPs (Fig. <xref rid="Fig1" ref-type="fig">1</xref>c (4)), producing significant <italic>p</italic> values for GATA4 (DNase <italic>p</italic> &lt; 10<sup>−10</sup>, H3K27ac <italic>p</italic> &lt; 10<sup>−5</sup>) and GATA6 (DNase <italic>p</italic> &lt; 10<sup>−13</sup>, H3K27ac <italic>p</italic> &lt; 10<sup>−7</sup>). After this analysis is conducted for all TR ChIP-seq samples in the Cistrome DB and the results are combined and compared, GATA6 and GATA4 ChIP-seq from intestinal and gastric tissues have the most significant <italic>p</italic> values (Fig. <xref rid="Fig2" ref-type="fig">2</xref>c, d).
<fig id="Fig2"><label>Fig. 2</label><caption><p>A downregulated gene set from a GATA6 knockdown experiment in gastric cancer KATO-III cells is used as a case study to demonstrate the Lisa framework. <bold>a</bold> Heatmap of regulatory potentials used to discriminate downregulated genes from non-regulated background genes. <bold>b</bold> In silico deletion analysis using GATA6 and CTCF cistromes to probe chromatin landscape models near an illustrative downregulated gene, LINC01133, and a background gene, ZC3H12A. Only the H3K27ac ChIP-seq and DNase-seq chromatin profiles with the largest positive coefficients are shown, although other samples contribute to the respective H3K27ac ChIP-seq and DNase-seq chromatin models. <bold>c</bold> Comparison of ΔRPs indicates GATA6 and GATA4 cistromes have a large impact on the chromatin landscapes near downregulated genes and are therefore likely to be regulators of the query gene set. CTCF does not influence the chromatin landscape of the downregulated genes and is not likely to regulate the query gene set. <bold>d</bold> The rank statistics for the Lisa analysis of the downregulated gene set in the GATA6 knockdown experiment were combined to get overall TR ranks. The top eight and the bottom eight TRs for all TR ChIP-seq samples are shown</p></caption><graphic xlink:href="13059_2020_1934_Fig2_HTML" id="MO2"/></fig></p>
    </sec>
    <sec id="Sec6">
      <title>Lisa identification of regulatory TF ChIP-seq sample clusters</title>
      <p id="Par13">To investigate whether a TF ChIP-seq cistrome derived from one cell type can be informative about other cell types, we first clustered all the human TR cistromes in the Cistrome DB based on the pairwise Pearson correlation of peak-RP scores as a heatmap (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). We then applied Lisa to differentially expressed gene sets defined by perturbations of individual TFs and examined the TR cistromes predicted to be the key regulators of these gene sets. In the analysis of upregulated genes on androgen receptor (AR) activation in the LNCaP prostate cancer cell line, Lisa identified a tight cluster of significant cistromes for AR and its known collaborator FOXA1 (Fig. <xref rid="Fig3" ref-type="fig">3</xref> (a)). All samples in this cluster were derived from prostate cancer cell lines. In the analysis of the GATA6 knockdown in the gastric cancer cell line (KATO-III), Lisa found the GATA6 and FOXA2 cistromes in the stomach and colon samples to be the most significant. FOXA2 is an important pioneer TF which has been reported to collaborate with GATA6 in gut development to regulate Wnt6 [<xref ref-type="bibr" rid="CR41">41</xref>] and Wnt7b [<xref ref-type="bibr" rid="CR42">42</xref>] (Fig. <xref rid="Fig3" ref-type="fig">3</xref> (b)). The identification of GATA6 cistromes in colon cancer cell lines, in addition to gastric cancer cell lines, shows that cistromes derived from cell types that are of related lineages can be used to inform the identification of the relevant regulators, even if the cell types are not the same. In the third example involving glucocorticoid receptor (GR) activation in the lung cancer cell line A549, Lisa correctly identified GR in A549 as a likely regulator and also identified GR in a different cell type HeLa (Fig. <xref rid="Fig3" ref-type="fig">3</xref> (c)). AR, a member of the same nuclear receptor family as GR, is also implicated by Lisa even though the AR cistrome samples do not cluster with GR cistrome samples and have less statistical significance.
<fig id="Fig3"><label>Fig. 3</label><caption><p>Lisa predicts key transcriptional regulators and assigns significance to each Cistrome DB cistrome. The large heatmap shows the hierarchical clustering of 8471 human Cistrome DB ChIP-seq cistromes based on peak-RP, with color representing Pearson correlation coefficients between peak-RPs. The three bars to the left of the heatmap display Lisa significance scores for differentially expressed genes sets derived from GR activation in the A549 cell line (upregulated), GATA6 knockdown in gastric cancer (downregulated), and AR activation in the LNCaP cell line (upregulated). Small heatmaps show details of the global heatmap relevant to (a) AR activation, (b) GATA6 knockdown, and (c) GR activation gene sets. In each case, the most significant cistromes are derived from the same cell type or lineage</p></caption><graphic xlink:href="13059_2020_1934_Fig3_HTML" id="MO3"/></fig></p>
      <p id="Par14">We carried out an analysis of the effects of removing ChIP-seq and DNase-seq data on Lisa’s accuracy. In particular, we tested Lisa’s performance on three upregulated gene sets: (1) GR-activated genes in breast cancer (MCF7), (2) GR-activated genes in lung cancer (A549), and (3) estrogen receptor (ER)-activated genes in MCF7 (Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Table S3). In these analyses, we assessed the effect of removing all relevant cell-line-specific (MCF7 or A549), H3K27ac ChIP-seq and DNase-seq data, or cell-line-specific TR ChIP-seq data (ER or GR). We also removed cell-line-specific TR ChIP-seq data together with H3K27ac ChIP-seq and DNase-seq data. We repeated the same analysis removing similar data, on the basis of tissue (breast and lung) instead of on the basis of cell line (MCF7 and A549). When MCF7 ER ChIP-seq are excluded, an ER sample from another breast cancer cell line (H3396) predicts the importance of ER (rank 6) as a regulator of the estrogen-activated gene set. When all ER breast ChIP-seq samples are excluded, Lisa can still identify ER (rank 18) from ER ChIP-seq in the VCaP prostate cancer cell line. For the GR-activated gene set in MCF7, when GR ChIP-seq data is unavailable in MCF7, Lisa can identify GR as a key regulator (rank 2) using GR ChIP-seq from the lung (A549). For the GR-activated gene set in the lung, Lisa identified GR as the key regulator (rank 1) using GR ChIP-seq data from the breast (MDA-MB-231). Together, these observations indicate that although TRs often bind in cell-type-specific ways, ChIP-seq-derived TR cistromes can be informative about the gene sets that TRs regulate in some other cell types.</p>
    </sec>
    <sec id="Sec7">
      <title>Lisa identification of TF-associated cofactors in addition to TFs</title>
      <p id="Par15">To illustrate Lisa’s capacity to find cofactors that interact with the regulatory TFs, we examined the Lisa analyses of four differentially expressed gene sets derived from experiments involving the activation of GR [<xref ref-type="bibr" rid="CR43">43</xref>] and the knockdown/out of BCL6 [<xref ref-type="bibr" rid="CR44">44</xref>], MYC [<xref ref-type="bibr" rid="CR45">45</xref>], and SOX2 [<xref ref-type="bibr" rid="CR46">46</xref>]. Lisa analysis of GR activation in lung cancer ranked GR itself as the most significant TR for the upregulated gene sets (Fig. <xref rid="Fig4" ref-type="fig">4</xref>a) and highly ranked pioneer TFs FOSL2 and CEBPB, which were downregulated after GR activation (Fig. <xref rid="Fig3" ref-type="fig">3</xref>c). BCL6, a predominantly repressive TF, is a driver of diffuse large B cell lymphoma (DLBCL) [<xref ref-type="bibr" rid="CR47">47</xref>]. Lisa analysis of the upregulated genes in a BCL6 knockdown experiment in a DLBCL cell line ranked BCL6 as the most significant TR for this gene set (Fig. <xref rid="Fig4" ref-type="fig">4</xref>b). Lisa also identified NCOR1 and NCOR2, which are transcriptional BCL6 corepressors involved in the regulation of the germinal center [<xref ref-type="bibr" rid="CR48">48</xref>–<xref ref-type="bibr" rid="CR50">50</xref>]. SPI1, which recruits BCL6 [<xref ref-type="bibr" rid="CR51">51</xref>], and BCOR, another BCL6 corepressor [<xref ref-type="bibr" rid="CR52">52</xref>], were ranked among the top TRs for the upregulated gene set. In a MYC knockdown experiment in medulloblastoma, MYC and its dimerization partner, MAX [<xref ref-type="bibr" rid="CR53">53</xref>], were among the top predicted regulators of the downregulated genes (Fig. <xref rid="Fig4" ref-type="fig">4</xref>c). The histone methyltransferase, KDM2B, known to physically interact with MYC and to augment MYC-regulated transcription [<xref ref-type="bibr" rid="CR54">54</xref>] was also detected among the top regulators. In the SOX2 knockout experiment [<xref ref-type="bibr" rid="CR2">2</xref>], NANOG, SOX2, and POU5F1, the key regulators of pluripotency, were the top predicted regulators of the downregulated genes (Fig. <xref rid="Fig4" ref-type="fig">4</xref>d). Lisa also discovered a similar set of TRs for the gene set derived from a POU5F1 knockdown experiment in embryonic stem cells (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S3,4a). In addition, β-catenin (CTNNB1), which interacts with SOX2 and is oncogenic in SOX2<sup>+</sup> cells [<xref ref-type="bibr" rid="CR55">55</xref>], also ranked high for the downregulated genes. The predicted regulators of the upregulated genes in this experiment include FOXA1 and EOMES. FOXA1 is involved in early embryonic development [<xref ref-type="bibr" rid="CR56">56</xref>] and has been observed to repress NANOG directly [<xref ref-type="bibr" rid="CR57">57</xref>]. FOXA1 has been shown through co-immunoprecipitation to physically interact with SOX2 [<xref ref-type="bibr" rid="CR58">58</xref>]. SOX2, known to bind to an enhancer regulating EOMES in human ESCs, when knocked down triggers EOMES expression and induces endoderm and trophectoderm differentiation [<xref ref-type="bibr" rid="CR59">59</xref>]. Thus, in many cases, the known interactors are highly ranked along with the target activator or repressor. This suggests that even though the available TF ChIP-seq data in different cell types are sparse (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1d), Lisa can provide insights on possible regulatory TFs since transcriptional machinery tends to be organized in modules of interacting factors [<xref ref-type="bibr" rid="CR60">60</xref>] (Additional file 1: Figure S4d).
<fig id="Fig4"><label>Fig. 4</label><caption><p>Lisa can accurately identify key transcriptional regulators and co-regulators using Cistrome DB cistromes. Lisa analyses of up- and downregulated gene sets from <bold>a</bold> GR overexpression, <bold>b</bold> BCL6 knockdown, <bold>c</bold> MYC knockdown, and <bold>d</bold> SOX2 knockout experiments. The scatter plots show negative log<sub>10</sub> Lisa <italic>p</italic> values of 1316 unique transcriptional regulators for up- and downregulated gene sets. Colors indicate log<sub>2</sub> fold changes of the TF gene expression between treatment and control conditions in the gene expression experiments. Dots outlined with a circle denote transcriptional regulators that physically interact with the TF perturbed in the experiment, which is marked with a cross</p></caption><graphic xlink:href="13059_2020_1934_Fig4_HTML" id="MO4"/></fig></p>
    </sec>
    <sec id="Sec8">
      <title>Systematic evaluation of regulator prediction</title>
      <p id="Par16">To systematically evaluate Lisa, we compiled a benchmark panel of 122 differentially expressed gene sets from 61 studies involving the knockdown, knockout, activation, or overexpression of 27 unique human target TFs. In addition, we compiled 112 differentially expressed gene sets derived from 56 studies with 25 unique TF perturbations in mice (Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Table S4, see “galleries” at <ext-link ext-link-type="uri" xlink:href="http://lisa.cistrome.org">http://lisa.cistrome.org</ext-link>). The full Lisa model was separately applied to the upregulated and downregulated gene sets in each experiment. We also carried out analyses of these gene sets using subcomponents of Lisa: the peak-RP method, as well as H3K27ac ChIP-seq- and DNase-seq-assisted ISD analyses. The putative regulatory cistromes were defined using either ChIP-seq peaks or from TF motif occurrence in the inferred chromatin models. The results allowed us to compare the effectiveness of DNase-seq and H3K27ac ChIP-seq in scenarios where the TF cistromes are well estimated (by ChIP-seq) or less well estimated (by motif). We measured the performance based on their ranking of the perturbed target TF (Fig. <xref rid="Fig5" ref-type="fig">5</xref>, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S5).
<fig id="Fig5"><label>Fig. 5</label><caption><p>Systematic evaluation of regulator prediction performance for humans using Cistrome DB ChIP-seq and DNA motif-derived cistromes. <bold>a</bold> Heatmap showing Lisa’s performance in the analysis of human TF perturbation experiments. Each column represents a TF activation/overexpression or knockdown/out experiment with similar experiment types grouped together. Rows represent the methods based on cistromes from TR ChIP-seq data or imputed from motifs. The upper left red triangles represent the rank of the target TFs based on the analysis of the upregulated gene sets; the lower right blue triangles represent the analysis of downregulated gene sets. The heatmap includes non-redundant human experiments for the same TF. See Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S5 for the complete list of human and mouse experiments. <bold>b</bold> Boxplot showing the target TF rankings comparing Lisa ChIP-seq-based methods and the baseline model based on TF peak counts in gene promoter regions to analyze up- and downregulated gene sets in overexpression/activation (OE) and knockdown/out experiments (KD/KO). <bold>c</bold> Boxplot showing target TF rankings using Lisa motif-based methods and the baseline model based on motif hits in promoter regions</p></caption><graphic xlink:href="13059_2020_1934_Fig5_HTML" id="MO5"/></fig></p>
      <p id="Par17">We compared the performance of methods that use TF ChIP-seq data and TF motifs, on up- and downregulated gene sets, and on overexpression/activation and knockdown/knockout samples (Fig. <xref rid="Fig5" ref-type="fig">5</xref>a). In overexpression studies, the prediction performance of all methods tended to be better for the upregulated gene sets than for the downregulated ones. The reverse is evident in the knockout and knockdown studies for which the prediction performances are better for the downregulated gene sets (Fig. <xref rid="Fig5" ref-type="fig">5</xref>b, c). This suggests that most of the TFs included in the study have a predominant activating role in the regulation of their target genes, under the conditions of the gene expression experiments, allowing these TFs to be more readily identified with the corresponding direction of primary gene expression response. Similar performance patterns were observed in the mouse benchmark datasets (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S5). The performances of Lisa using ISD of TR ChIP-seq peak from chromatin landscapes were similar to the TR ChIP-seq peak-RP method, but outperformed motif-based methods by large margins.</p>
      <p id="Par18">To determine whether differences between the up- and downregulated gene sets could be explained by direct or indirect modes of TR recruitment, we studied two experiments involving ER and GR activation in greater detail. We defined “direct” ER and GR binding sites as ER/GR ChIP-seq peaks on genomic intervals containing the cognate DNA sequence elements and “indirect” ER and GR binding sites as ER/GR ChIP-seq peaks without the sequence elements. Comparing direct and indirect binding sites in the respective ER and GR activation experiments (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S6), we found that the upregulated gene sets were more significantly associated with the direct binding sites (ER <italic>p</italic> value 1.5 × 10<sup>−15</sup>, GR <italic>p</italic> value 1.5 × 10<sup>−18</sup>) than with the indirect ones (ER <italic>p</italic> value 3.8 × 10<sup>−4</sup>, GR <italic>p</italic> value 1.4 × 10<sup>−12</sup>). The downregulated gene sets were more significantly associated with the indirect binding sites (ER <italic>p</italic> value 1.5 × 10<sup>−15</sup>, GR <italic>p</italic> value 1.5 × 10<sup>−11</sup>) than with the direct ones (ER <italic>p</italic> value 4.6 × 10<sup>−2</sup>, GR <italic>p</italic> value 3.0 × 10<sup>−3</sup>).</p>
      <p id="Par19">In some cases, the perturbation of a TR may trigger stress, immune, or cell cycle checkpoint responses that are not directly related to the initial perturbation. In the Lisa analysis of upregulated genes after 24 h of estradiol stimulation (GSE26834), for example, E2F4 is the top-ranked TR, followed by ER. Estrogen is known to stimulate the proliferation of breast cancer cells via a pathway involving E2F4, a key regulator of the G1/S cell cycle checkpoint [<xref ref-type="bibr" rid="CR61">61</xref>]. In this case, Lisa might be correctly detecting a secondary response to the primary TR perturbation.</p>
    </sec>
    <sec id="Sec9">
      <title>Comparison of Lisa with published methods</title>
      <p id="Par20">We next compared Lisa with other approaches, including BART [<xref ref-type="bibr" rid="CR29">29</xref>], i-cisTarget [<xref ref-type="bibr" rid="CR30">30</xref>], and Enrichr [<xref ref-type="bibr" rid="CR31">31</xref>], which can use either TR ChIP-seq data or motifs. We also included a baseline method that ranks TRs by comparing query and background gene sets based on the TR binding site number within 5 kb centered on the TSS. Lisa outperformed BART, i-cisTarget, and Enrichr in terms of the percentage of the target TR identified within the top ten across all the experiments, either using TF binding sites from ChIP-seq data or motif hits (Fig. <xref rid="Fig6" ref-type="fig">6</xref>a, b). Lisa uses a model based on chromatin data to give more weight to the loci that are more likely to influence the expression of the query gene set. In this way, Lisa improves the performance of TR inference with noisy cistrome profiles such as those imputed from DNA sequence motifs. In addition to being more accurate than other methods in terms of TR prediction, the Lisa web server (<ext-link ext-link-type="uri" xlink:href="http://lisa.cistrome.org">lisa.cistrome.org</ext-link>) has several unique features that allow investigators to explore relevant ChIP-seq data in ways that are not available in other applications.
<fig id="Fig6"><label>Fig. 6</label><caption><p>Lisa’s performance surpasses published models. Lisa’s performance is compared with alternative published methods for <bold>a</bold> upregulated genes in overexpression/activation experiments and <bold>b</bold> downregulated genes in knockdown/out experiments</p></caption><graphic xlink:href="13059_2020_1934_Fig6_HTML" id="MO6"/></fig></p>
    </sec>
    <sec id="Sec10">
      <title>Lisa web site and gallery of Lisa’s benchmark data</title>
      <p id="Par21">The Lisa web site (<ext-link ext-link-type="uri" xlink:href="http://lisa.cistrome.org">lisa.cistrome.org</ext-link>) displays two tables of results for each query gene set. The first summarizes the Lisa analysis based on TR ChIP-seq data, and the second displays the Lisa analysis of TF binding sites imputed from DNA binding motifs. The ChIP-seq data table displays up to five ChIP-seq samples for each TR. Users can sort results by <italic>p</italic> value and inspect metadata and quality control statistics for each of the ChIP-seq samples to understand whether the predictive samples may be derived from particular cell types or experimental conditions. Lisa provides quality control metrics, metadata, publication, and read data repository links for the ChIP-seq data of putative regulatory TRs. Through Lisa, the ChIP-seq signal tracks can be viewed on the WashU Epigenome Browser [<xref ref-type="bibr" rid="CR62">62</xref>]. Although the motif imputation-based analysis tends to be less accurate than the ChIP-seq based analysis, motifs can indicate roles for regulatory TRs for which ChIP-seq data is not widely available. Lisa’s analysis of all the benchmark gene sets is also viewable on the Lisa web site. Users can explore these analyses to understand the “typical” results of the analysis. Robust methods combined with visualization and data exploration features make Lisa a valuable tool for analyzing gene regulation in humans and mice.</p>
    </sec>
  </sec>
  <sec id="Sec11">
    <title>Conclusion</title>
    <p id="Par22">In this study, we describe an approach for using publicly available ChIP-seq and DNase-seq data to identify the regulators of differentially expressed gene sets in humans and mice. On the basis of a series of benchmarks, we demonstrate the effectiveness of our method and report recurrent patterns in the TRs predicted by these methods. We find the regulators of the upregulated genes and the downregulated ones are often different from each other; therefore, in any analysis of differential gene expression, up- and downregulated gene sets ought to be distinguished. Our results show that many TFs have a preferred directionality of effect, indicative of a predominant repressive or activating function. It is well known that many TFs can recruit both activating and repressive complexes [<xref ref-type="bibr" rid="CR63">63</xref>], so the observed direction may be related to the stoichiometry and affinity of the activating or repressive cofactors. We also observe differences between ChIP-seq-based analysis and motif-based ones, suggesting differences in the TF activity depending on whether a TF interacts directly with DNA or whether it is recruited via another TF [<xref ref-type="bibr" rid="CR64">64</xref>]. When a TF is recruited by another TF, it is likely that the enhancer has been already established by other TFs and protein complexes. Thus, the co-binding enhancer information of multiple TFs allows Lisa to identify both the DNA-bound TFs and their partners which might not directly bind DNA.</p>
    <p id="Par23">Lisa’s accuracy in predicting the regulatory TRs of a gene set depends on the perturbation used in the production of the differential gene expression data; the quality of the gene expression data; the availability and quality of the DNase-seq, H3K27ac, and TR ChIP-seq data sets; the degree to which binding is dependent on a DNA sequence motif; and the validity of the model assumptions. Although we evaluate Lisa using differential gene expression data associated with a TR perturbation, the perturbed TR might not be the main regulator of the gene set. For example, perturbation of a TR may trigger a stress response [<xref ref-type="bibr" rid="CR65">65</xref>] or secondary transcriptional effects that are not directly related to the primary TR [<xref ref-type="bibr" rid="CR66">66</xref>].</p>
    <p id="Par24">The modeling approach used in Lisa facilitates the prediction of regulatory TRs using available ChIP-seq and DNase-seq data. DNase-seq and H3K27ac ChIP-seq are available in a broad variety of cell types, and these data are informative about <italic>cis</italic>-regulatory events mediated by many TRs. Although H3K27ac is considered to be a histone modification associated with gene activation, Lisa can still identify TRs, such as BCL6 and EZH2, with predominantly repressive functions. Although Lisa uses the correlation between H3K27ac or chromatin accessibility and gene expression to predict regulatory TRs, we do not assume that H3K27ac or chromatin accessibility causes the transcriptional changes. Other genomics data types that are predictive of general <italic>cis</italic>-regulatory activity, when available in quantity, variety, and quality, might improve Lisa’s performance. More importantly, high-quality TR-specific binding data, generated by ChIP-seq or alternative technologies, like CETCh-seq [<xref ref-type="bibr" rid="CR14">14</xref>] or CUT &amp; RUN [<xref ref-type="bibr" rid="CR15">15</xref>], will be needed to improve Lisa’s accuracy in predicting TRs that are not yet well represented in Cistrome DB. TR imputation methods might fill in some gaps in TR binding data; however, families of TRs such as homeobox and forkhead factors, which have similar DNA-binding motifs, can be hard to discriminate based on DNA sequence analysis.</p>
    <p id="Par25">Although Lisa aims to identify the regulators of any differentially expressed gene set in humans or mice, no matter the contrast, in practice, the query gene sets should be derived from biologically meaningful differential expression or co-regulation analyses. In this study, we based the method evaluation on data from available TR perturbation experiments, which are biased towards well-studied systems. For this reason, the reliability of methods based on TR ChIP-seq data may be overestimated relative to imputation-based methods because the available TR ChIP-seq data tends to be derived from similar cell types and for the same factors used in the gene perturbation experiments. When the relevant cell-type-specific TR ChIP-seq data is available, the performance of the peak-RP method and ISD methods are similar, but when TR ChIP-seq data is not available, methods based on imputed TR cistromes are obligatory. The value of imputed cistromes relative to ChIP-seq derived ones will depend on the quantity, variety, and quality of available ChIP-seq data; the accuracy of the imputed cistromes; the degree of commonality of the genes that are regulated by the same TR in different cell types; and the number of TRs recognizing similar DNA sequence elements. Lisa provides invaluable information about the regulation of gene sets derived from both bulk and single-cell expression profiles [<xref ref-type="bibr" rid="CR67">67</xref>] and will become more accurate over time with greater coverage of TF ChIP-seq augmented by computationally imputed TF cistromes.</p>
  </sec>
  <sec id="Sec12">
    <title>Methods</title>
    <sec id="Sec13">
      <title>Preprocessing of chromatin profiles</title>
      <p id="Par26">Using the BigWig format signal tracks of human and mouse H3K27ac ChIP-seq and DNase-seq from Cistrome DB, we precomputed the chromatin profile regulatory potential (chrom-RP) of each RefSeq gene and also summarized the signal in 1-kb windows genome-wide. The chrom-RP for gene <italic>k</italic> in sample <italic>j</italic> is defined as <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {R}_{jk}={\sum}_{i\in \left[{t}_k-L,{t}_k+L\right]}{w}_i{s}_{ji} $$\end{document}</tex-math><mml:math id="M2" display="inline"><mml:msub><mml:mi>R</mml:mi><mml:mi mathvariant="italic">jk</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>∈</mml:mo><mml:mfenced close="]" open="[" separators=","><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:mi>L</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mi>L</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:msub><mml:msub><mml:mi>w</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mi>s</mml:mi><mml:mi mathvariant="italic">ji</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="13059_2020_1934_Article_IEq1.gif"/></alternatives></inline-formula> (as defined in the MARGE algorithm [<xref ref-type="bibr" rid="CR28">28</xref>]). <italic>L</italic> is set to 100 kb, and <italic>w</italic><sub><italic>i</italic></sub> is a weight representing the regulatory influence of a locus at position <italic>i</italic> on the TSS of gene <italic>k</italic> at genomic position <italic>t</italic><sub><italic>k</italic></sub>, <italic>w</italic><sub><italic>i</italic></sub> = 2<italic>e</italic><sup>−<italic>μd</italic></sup>/1 + <italic>e</italic><sup>−<italic>μd</italic></sup>, where <italic>d</italic> = |<italic>i</italic> − <italic>t</italic><sub><italic>k</italic></sub>|/<italic>L</italic>, and <italic>i</italic> stands for <italic>i</italic>th nucleotide position within the [−<italic>L</italic>, <italic>L</italic>] genomic interval centered on the TSS at <italic>t</italic><sub><italic>k</italic></sub>. <italic>s</italic><sub><italic>ji</italic></sub> is the signal of chromatin profile <italic>j</italic> at position <italic>i</italic>. <italic>μ</italic> is the parameter to determine the decay rate of the weight, which is defined as <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \mu =-\ln \raisebox{1ex}{$L$}\!\left/ \!\raisebox{-1ex}{$3\Delta $}\right. $$\end{document}</tex-math><mml:math id="M4" display="inline"><mml:mi>μ</mml:mi><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mo>ln</mml:mo><mml:mfrac bevelled="true"><mml:mi>L</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi mathvariant="normal">Δ</mml:mi></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="13059_2020_1934_Article_IEq2.gif"/></alternatives></inline-formula>. For DNase-seq and H3K27ac ChIP-seq, the decay distance Δ is set to 10 kb. The genome-wide read counts on 1-kb windows were calculated using the UCSC utility bigWigAverageOverBed [<xref ref-type="bibr" rid="CR68">68</xref>]. The chrom-RP matrix for chromatin profiles was normalized across RefSeq genes within one chromatin profile by <inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {R}_{jk}^{\prime }=\log \left({R}_{jk}+1\right)-\frac{1}{k}{\sum}_1^k\left(\log \left({R}_{jk}+1\right)\right) $$\end{document}</tex-math><mml:math id="M6" display="inline"><mml:msubsup><mml:mi>R</mml:mi><mml:mi mathvariant="italic">jk</mml:mi><mml:mo>′</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:mo>log</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi mathvariant="italic">jk</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced><mml:mo>−</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:mfrac><mml:msubsup><mml:mo>∑</mml:mo><mml:mn>1</mml:mn><mml:mi>k</mml:mi></mml:msubsup><mml:mfenced close=")" open="("><mml:mrow><mml:mo>log</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi mathvariant="italic">jk</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="13059_2020_1934_Article_IEq3.gif"/></alternatives></inline-formula>.</p>
    </sec>
    <sec id="Sec14">
      <title>Preprocessing of cistromes</title>
      <p id="Par27"> We converted TR ChIP-seq peaks from the Cistrome Data Browser (v.1) BED files into binary values to represent binding within 100bp resolution genomic intervals. DNA sequence scores were calculated from Cistrome DB position weight matrices, a redundant collection of 1,061 PWMs from TRANSFAC [<xref ref-type="bibr" rid="CR69">69</xref>], JASPAR [<xref ref-type="bibr" rid="CR70">70</xref>] and Cistrome DB ChIP-seq, representing 675 unique TFs in human and mouse. The peak-based regulatory potential (peak-RP) of a TR cistrome is defined in the same way as the chrom-RP except <italic>s</italic><sub><italic>i</italic></sub> represents the presence (<italic>s</italic><sub><italic>ji</italic></sub> = 1) or absence (<italic>s</italic><sub><italic>ji</italic></sub> = 0) of a peak summit within the upstream and downstream 100 kb centered on TSS. The genome-wide motif scores were scanned at a 100-bp window size with the library (<ext-link ext-link-type="uri" xlink:href="https://github.com/qinqian/seqpos2">https://github.com/qinqian/seqpos2</ext-link>) [<xref ref-type="bibr" rid="CR71">71</xref>], and the motif hits are defined by thresholding at the 99th percentiles then mapped to the 1-kb windows. The genome-wide 1-kb windows in which the TR peak summits are located were determined using Bedtools [<xref ref-type="bibr" rid="CR72">72</xref>]. All of the peak-RPs, TR binding, and motif hit data were deposited into hdf5 format files.</p>
    </sec>
    <sec id="Sec15">
      <title>Lisa framework</title>
      <sec id="Sec16">
        <title>Chromatin landscape model</title>
        <p id="Par28">Lisa selects 3000 background genes by proportionally sampling from non-query genes with a range of different TAD and promoter activities based on compendia of Cistrome DB H3K4me3 and H3K27ac ChIP-seq signals. There is no gene ontology enrichment in the background gene set. Lisa then uses L1-regularized logistic regression to select an optimum sample set for H3K27ac ChIP-seq or DNase-seq samples based on <inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {R}_{jk}^{\prime } $$\end{document}</tex-math><mml:math id="M8" display="inline"><mml:msubsup><mml:mi>R</mml:mi><mml:mi mathvariant="italic">jk</mml:mi><mml:mo>′</mml:mo></mml:msubsup></mml:math><inline-graphic xlink:href="13059_2020_1934_Article_IEq4.gif"/></alternatives></inline-formula>. The L1 penalty parameter is determined by binary search to constrain the number of selected chromatin profiles to be small but sufficient to capture the information (different sample sizes were explored, and 10 was used in all the benchmark cases [<xref ref-type="bibr" rid="CR28">28</xref>]). Lisa trains a final logistic regression model to predict the target gene set and obtains a weight <italic>α</italic><sub><italic>j</italic></sub> for each candidate chromatin profile <italic>j</italic>, from which the weighted sum of chrom-RP is the model regulatory potential (model-RP).</p>
      </sec>
      <sec id="Sec17">
        <title>In silico deletion method</title>
        <p id="Par29">The rationale for the ISD method is that the peaks of the true regulatory TFs should align with the high chromatin accessibility signals from the corresponding tissue or cell type. Therefore, the computational deletion of the chromatin signals on the peaks of regulatory cistromes would result in a more substantial effect on the model-RP for query genes than for background genes. The regulatory potentials are recalculated after erasing the signal in all 1-kb windows containing at least one peak from a putative regulatory cistrome <italic>i</italic>, <inline-formula id="IEq5"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\overset{\sim }{R}}_{ijk}={R}_{jk}-{\sum}_{m\in {M}_{ik}}l\ {w}_m{s}_{jm} $$\end{document}</tex-math><mml:math id="M10" display="inline"><mml:msub><mml:mover accent="true"><mml:mi>R</mml:mi><mml:mo stretchy="true">~</mml:mo></mml:mover><mml:mi mathvariant="italic">ijk</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mi mathvariant="italic">jk</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mo>∑</mml:mo><mml:mrow><mml:mi>m</mml:mi><mml:mo>∈</mml:mo><mml:msub><mml:mi>M</mml:mi><mml:mi mathvariant="italic">ik</mml:mi></mml:msub></mml:mrow></mml:msub><mml:mi>l</mml:mi><mml:mspace width="0.25em"/><mml:msub><mml:mi>w</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:msub><mml:mi>s</mml:mi><mml:mi mathvariant="italic">jm</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="13059_2020_1934_Article_IEq5.gif"/></alternatives></inline-formula> (where <italic>M</italic><sub><italic>ik</italic></sub> is the set of 1-kb windows containing at least one peak in cistrome <italic>i</italic> for gene <italic>k</italic>; <italic>l</italic> is the window size, which is set to 1 kb for this study; <italic>w</italic><sub><italic>m</italic></sub> is the exponential decay weight with the distance between the <italic>m</italic>th window center and TSS, the weight function is the same as chrom-RP; and <italic>s</italic><sub><italic>jm</italic></sub> is the <italic>j</italic>th average chromatin profile signal on the <italic>m</italic>th window). These RPs are then normalized using the same normalization factors from the original RPs <inline-formula id="IEq6"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\overset{\sim }{R}}_{ijk}^{\prime }=\log \left({\overset{\sim }{R}}_{ijk}+1\right)-\frac{1}{K}{\sum}_1^K\left(\log \left({R}_{jk}+1\right)\right). $$\end{document}</tex-math><mml:math id="M12" display="inline"><mml:msubsup><mml:mover accent="true"><mml:mi>R</mml:mi><mml:mo stretchy="true">~</mml:mo></mml:mover><mml:mi mathvariant="italic">ijk</mml:mi><mml:mo>′</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:mo>log</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>R</mml:mi><mml:mo stretchy="true">~</mml:mo></mml:mover><mml:mi mathvariant="italic">ijk</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced><mml:mo>−</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>K</mml:mi></mml:mfrac><mml:msubsup><mml:mo>∑</mml:mo><mml:mn>1</mml:mn><mml:mi>K</mml:mi></mml:msubsup><mml:mfenced close=")" open="("><mml:mrow><mml:mo>log</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi mathvariant="italic">jk</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:math><inline-graphic xlink:href="13059_2020_1934_Article_IEq6.gif"/></alternatives></inline-formula></p>
        <p id="Par30">After deletion, the model RPs are recalculated using the weights from the logistic regression model from chromatin profile feature selection without refitting and subtracted from the non-deletion model-RP, producing a ΔRP value for each gene, defined as the linear combination of differences in regulatory potentials: <inline-formula id="IEq7"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \Delta {R}_{ik}^{\prime }={\sum}_j{\alpha}_j\Big({R}_{jk}^{\prime }-{\overset{\sim }{R}}_{ijk}^{\prime } $$\end{document}</tex-math><mml:math id="M14" display="inline"><mml:mi mathvariant="normal">Δ</mml:mi><mml:msubsup><mml:mi>R</mml:mi><mml:mi mathvariant="italic">ik</mml:mi><mml:mo>′</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:msub><mml:mo>∑</mml:mo><mml:mi>j</mml:mi></mml:msub><mml:msub><mml:mi>α</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo stretchy="true">(</mml:mo><mml:msubsup><mml:mi>R</mml:mi><mml:mi mathvariant="italic">jk</mml:mi><mml:mo>′</mml:mo></mml:msubsup><mml:mo>−</mml:mo><mml:msubsup><mml:mover accent="true"><mml:mi>R</mml:mi><mml:mo stretchy="true">~</mml:mo></mml:mover><mml:mi mathvariant="italic">ijk</mml:mi><mml:mo>′</mml:mo></mml:msubsup></mml:math><inline-graphic xlink:href="13059_2020_1934_Article_IEq7.gif"/></alternatives></inline-formula>).</p>
      </sec>
      <sec id="Sec18">
        <title>Combined statistics method for TR ranking</title>
        <p id="Par31">The peak-RPs or ΔRPs of the query gene set are compared with that of the background gene set through the one-sided Wilcoxon rank-sum test. For ChIP-seq-based methods, peak-RP, DNase-seq, and H3K27ac chom-RP are combined to get a robust prediction of the TRs. For motif-based methods, DNase-seq and H3K27ac ΔRPs are combined to get the final inference of TRs. Both combinations of statistics follow the Cauchy combination test [<xref ref-type="bibr" rid="CR38">38</xref>], in which the combined statistics for each TR is <inline-formula id="IEq8"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {t}_j=\sum \limits_{i=1}^d{w}_i\tan \left\{\left(0.5-{p}_i\right)\pi \right\} $$\end{document}</tex-math><mml:math id="M16" display="inline"><mml:msub><mml:mi>t</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>d</mml:mi></mml:munderover><mml:msub><mml:mi>w</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>tan</mml:mo><mml:mfenced close="}" open="{"><mml:mrow><mml:mfenced close=")" open="("><mml:mrow><mml:mn>0.5</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mi>π</mml:mi></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="13059_2020_1934_Article_IEq8.gif"/></alternatives></inline-formula>, where <italic>j</italic> represents one TR, <italic>i</italic> represents the <italic>i</italic>th method within ChIP-seq-based or motif-based methods, <italic>p</italic><sub><italic>i</italic></sub> is the corresponding <italic>p</italic> value, and <italic>w</italic><sub><italic>i</italic></sub> is set to 1/<italic>d</italic> where <italic>d</italic> is 3 for ChIP-seq-based method or 2 for the motif-based method. The combined <italic>p</italic> value for a TR <italic>j</italic> is computed as <italic>p</italic><sub><italic>j</italic></sub> = 1/2 − (arctan(<italic>t</italic><sub><italic>j</italic></sub>))/<italic>π</italic>.</p>
      </sec>
      <sec id="Sec19">
        <title>Baseline method</title>
        <p id="Par32">The baseline method, which is the “peaks in promoter” for ChIP-seq-based method or “hits in promoter” for the motif-based method, is implemented by counting the number of TF ChIP-seq binding summits or motif hits within the genomic interval from 5 kb upstream to 5 kb downstream of the TSS. The peaks or motif counts in the promoter of the target gene set are compared with that of the background gene set using the one-sided Wilcoxon rank-sum test.</p>
      </sec>
      <sec id="Sec20">
        <title>Comparison of “direct” and “indirect” binding sites</title>
        <p id="Par33">For up- and downregulated gene sets from the same experiment, the peaks of the target TR ChIP-seq samples with the most significant <italic>p</italic> values are defined as “direct” or “indirect” binding sites based on the target TR motif scores. Peak-RPs of “direct” or “indirect” binding sites are calculated and normalized to percentiles. Statistical significance between query and background gene sets was calculated by the one-sided Wilcoxon rank-sum test.</p>
      </sec>
      <sec id="Sec21">
        <title>Comparison of Lisa with published methods</title>
        <p id="Par34">All up- and downregulated gene sets in Lisa’s benchmark dataset were also used to test other published methods. BART and i-cisTarget were manually run through online websites with the default settings. Enrichr was run using the API. When comparing the motif-based methods, PWMs from species other than humans or mice were removed since they are not included in the Lisa framework: BART (<ext-link ext-link-type="uri" xlink:href="http://bartweb.org/">http://bartweb.org/</ext-link>), i-cisTarget (<ext-link ext-link-type="uri" xlink:href="https://gbiomed.kuleuven.be/apps/lcb/i-cisTarget/?ref=labworm">https://gbiomed.kuleuven.be/apps/lcb/i-cisTarget/?ref=labworm</ext-link>), and Enrichr (<ext-link ext-link-type="uri" xlink:href="http://amp.pharm.mssm.edu/Enrichr/">http://amp.pharm.mssm.edu/Enrichr/</ext-link>).</p>
      </sec>
      <sec id="Sec22">
        <title>Lisa pipeline</title>
        <p id="Par35">The Lisa pipeline is implemented with Snakemake [<xref ref-type="bibr" rid="CR73">73</xref>]. Lisa contains an interface to process FASTQ format files to BigWig format files and to generate hdf5 files containing the chrom-RP matrices and 1-kb resolution data required by the Lisa model module.</p>
      </sec>
      <sec id="Sec23">
        <title>Lisa online application</title>
        <p id="Par36">We have implemented the online version of Lisa (<ext-link ext-link-type="uri" xlink:href="http://lisa.cistrome.org">http://lisa.cistrome.org</ext-link>) using the Flask Python web development framework, along with process control software Celery to queue numerous queries. The analysis result of the target gene set is closely linked to the Cistrome DB. The scatterplot comparing TR ranking results from a pair of query gene sets such as up- and downregulated gene sets are implemented in <ext-link ext-link-type="uri" xlink:href="http://plot.ly">Plot.ly</ext-link>.</p>
      </sec>
    </sec>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary information</title>
    <sec id="Sec24">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="13059_2020_1934_MOESM1_ESM.pdf">
            <caption>
              <p><bold>Additional file 1.</bold> Figure S1-S6.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM2">
          <media xlink:href="13059_2020_1934_MOESM2_ESM.xlsx">
            <caption>
              <p><bold>Additional file 2:</bold> Table S1. Cistrome profile annotation table including TR ChIP-seq and TF motifs.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM3">
          <media xlink:href="13059_2020_1934_MOESM3_ESM.xlsx">
            <caption>
              <p><bold>Additional file 3:</bold> Table S2. DNase-seq and H3K27ac sample annotation table for mouse and human.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM4">
          <media xlink:href="13059_2020_1934_MOESM4_ESM.xlsx">
            <caption>
              <p><bold>Additional file 4:</bold> Table S3. Analysis of Lisa predictions of GR and ER regulated genes using data which does not match the specific cell type. The cell line and cell type of the highest ranked Lisa predicted target TR sample are shown in parentheses in each case.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM5">
          <media xlink:href="13059_2020_1934_MOESM5_ESM.xlsx">
            <caption>
              <p><bold>Additional file 5:</bold> Table S4. TF perturbation DNA microarray meta table for benchmarking the peak-RP and Lisa methods.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM6">
          <media xlink:href="13059_2020_1934_MOESM6_ESM.pdf">
            <caption>
              <p><bold>Additional file 6:</bold> Review history.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher’s Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
    <fn>
      <p>Qian Qin and Jingyu Fan contributed equally to this work and can interchangeably be ordered as co-first authors.</p>
    </fn>
  </fn-group>
  <sec>
    <title>Supplementary information</title>
    <p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s13059-020-1934-6.</p>
  </sec>
  <ack>
    <sec id="FPar1">
      <title>Peer review information</title>
      <p id="Par37">Kevin Pang was the primary editor of this article and managed its editorial process and peer review in collaboration with the rest of the editorial team.</p>
    </sec>
    <sec id="FPar2">
      <title>Review history</title>
      <p id="Par38">The review history is available as Additional file <xref rid="MOESM6" ref-type="media">6</xref>.</p>
    </sec>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>CM, XSL, and MB conceived the concept and initiated the project. CM, QQ, and JF developed the Lisa algorithm. QQ implemented the Lisa software and website. JF and QQ evaluated Lisa’s performance and carried out the analysis of the results. JF collected and processed the gene expression data. JF, QQ, RZ, CW, QW, and HS collected and processed the ChIP-seq and DNase-seq data. CM, XSL, and JZ supervised the project. CM, XSL, QQ, JF, and JZ wrote the paper. All authors read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This work was supported by grants from the NIH (U24 HG009446 to XLS, U24 CA237617 to XSL and CM), National Natural Science Foundation of China (31801110 to SM), and the Shanghai Sailing Program (18YF1402500 to QQ).</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>Lisa is available under the MIT open source license at <ext-link ext-link-type="uri" xlink:href="https://github.com/liulab-dfci/lisa">https://github.com/liulab-dfci/lisa</ext-link> [<xref ref-type="bibr" rid="CR74">74</xref>] and at Zenodo [<xref ref-type="bibr" rid="CR75">75</xref>]. All TR ChIP-seq, DNase-seq, and H3K27ac ChIP-seq data are from the Cistrome Data Browser (<ext-link ext-link-type="uri" xlink:href="http://cistrome.org/db">http://cistrome.org/db</ext-link>) [<xref ref-type="bibr" rid="CR71">71</xref>]. Gene expression profiles used for benchmarking the method were accessed at Gene Expression Omnibus (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo/</ext-link>). The lists of all the data used in this study are available in the additional files. The processed gene lists and Lisa results are available at the gallery of the Lisa server (<ext-link ext-link-type="uri" xlink:href="http://lisa.cistrome.org">http://lisa.cistrome.org</ext-link>).</p>
  </notes>
  <notes>
    <title>Ethics approval and consent to participate</title>
    <p id="Par39">Not applicable.</p>
  </notes>
  <notes notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par40">MB receives sponsored research support from Novartis. MB serves on the SAB of Kronos Bio and is a consultant to H3 Biomedicine. XSL is a cofounder and board member of GV20 Oncotherapy, SAB of 3DMed Care, consultant for Genentech, and stockholder of BMY, TMO, WBA, ABT, ABBV, and JNJ. All other authors declare that they have no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hanahan</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Weinberg</surname>
            <given-names>RA</given-names>
          </name>
        </person-group>
        <article-title>Hallmarks of cancer: the next generation</article-title>
        <source>Cell</source>
        <year>2011</year>
        <volume>144</volume>
        <fpage>646</fpage>
        <lpage>674</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2011.02.013</pub-id>
        <pub-id pub-id-type="pmid">21376230</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Takahashi</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Yamanaka</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors</article-title>
        <source>Cell</source>
        <year>2006</year>
        <volume>126</volume>
        <fpage>663</fpage>
        <lpage>676</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2006.07.024</pub-id>
        <pub-id pub-id-type="pmid">16904174</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Thurman</surname>
            <given-names>RE</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The accessible chromatin landscape of the human genome</article-title>
        <source>Nature</source>
        <year>2012</year>
        <volume>489</volume>
        <fpage>75</fpage>
        <lpage>82</lpage>
        <pub-id pub-id-type="doi">10.1038/nature11232</pub-id>
        <?supplied-pmid 22955617?>
        <pub-id pub-id-type="pmid">22955617</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gerstein</surname>
            <given-names>MB</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Architecture of the human regulatory network derived from ENCODE data</article-title>
        <source>Nature</source>
        <year>2012</year>
        <volume>488</volume>
        <fpage>91</fpage>
        <lpage>100</lpage>
        <pub-id pub-id-type="doi">10.1038/nature11245</pub-id>
        <pub-id pub-id-type="pmid">22859207</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Creyghton</surname>
            <given-names>MP</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Histone H3K27ac separates active from poised enhancers and predicts developmental state</article-title>
        <source>Proc. Natl. Acad. Sci. U. S. A.</source>
        <year>2010</year>
        <volume>107</volume>
        <fpage>21931</fpage>
        <lpage>21936</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1016071107</pub-id>
        <?supplied-pmid 21106759?>
        <pub-id pub-id-type="pmid">21106759</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Heinz</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities</article-title>
        <source>Mol. Cell</source>
        <year>2010</year>
        <volume>38</volume>
        <fpage>576</fpage>
        <lpage>589</lpage>
        <pub-id pub-id-type="doi">10.1016/j.molcel.2010.05.004</pub-id>
        <?supplied-pmid 2898526?>
        <pub-id pub-id-type="pmid">20513432</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>He</surname>
            <given-names>HH</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Nucleosome dynamics define transcriptional enhancers</article-title>
        <source>Nat. Genet.</source>
        <year>2010</year>
        <volume>42</volume>
        <fpage>343</fpage>
        <lpage>347</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.545</pub-id>
        <?supplied-pmid 20208536?>
        <pub-id pub-id-type="pmid">20208536</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mikkelsen</surname>
            <given-names>TS</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Genome-wide maps of chromatin state in pluripotent and lineage-committed cells</article-title>
        <source>Nature</source>
        <year>2007</year>
        <volume>448</volume>
        <fpage>553</fpage>
        <lpage>560</lpage>
        <pub-id pub-id-type="doi">10.1038/nature06008</pub-id>
        <?supplied-pmid 17603471?>
        <pub-id pub-id-type="pmid">17603471</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Johnson</surname>
            <given-names>D. S.</given-names>
          </name>
          <name>
            <surname>Mortazavi</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Myers</surname>
            <given-names>R. M.</given-names>
          </name>
          <name>
            <surname>Wold</surname>
            <given-names>B.</given-names>
          </name>
        </person-group>
        <article-title>Genome-Wide Mapping of in Vivo Protein-DNA Interactions</article-title>
        <source>Science</source>
        <year>2007</year>
        <volume>316</volume>
        <issue>5830</issue>
        <fpage>1497</fpage>
        <lpage>1502</lpage>
        <pub-id pub-id-type="doi">10.1126/science.1141319</pub-id>
        <?supplied-pmid 17540862?>
        <pub-id pub-id-type="pmid">17540862</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lambert</surname>
            <given-names>SA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The human transcription factors</article-title>
        <source>Cell</source>
        <year>2018</year>
        <volume>172</volume>
        <fpage>650</fpage>
        <lpage>665</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2018.01.029</pub-id>
        <?supplied-pmid 29425488?>
        <pub-id pub-id-type="pmid">29425488</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fulton</surname>
            <given-names>DL</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>TFCat: the curated catalog of mouse and human transcription factors</article-title>
        <source>Genome Biol.</source>
        <year>2009</year>
        <volume>10</volume>
        <fpage>R29</fpage>
        <pub-id pub-id-type="doi">10.1186/gb-2009-10-3-r29</pub-id>
        <?supplied-pmid 19284633?>
        <pub-id pub-id-type="pmid">19284633</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mei</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Cistrome Data Browser: a data portal for ChIP-Seq and chromatin accessibility data in human and mouse</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2017</year>
        <volume>45</volume>
        <fpage>D658</fpage>
        <lpage>D662</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkw983</pub-id>
        <?supplied-pmid 27789702?>
        <pub-id pub-id-type="pmid">27789702</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <collab>ENCODE</collab>
        </person-group>
        <article-title>An integrated encyclopedia of DNA elements in the human genome</article-title>
        <source>Nature</source>
        <year>2012</year>
        <volume>489</volume>
        <fpage>57</fpage>
        <lpage>74</lpage>
        <pub-id pub-id-type="doi">10.1038/nature11247</pub-id>
        <pub-id pub-id-type="pmid">22955616</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Savic</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>CETCh-seq: CRISPR epitope tagging ChIP-seq of DNA-binding proteins</article-title>
        <source>Genome Res.</source>
        <year>2015</year>
        <volume>25</volume>
        <fpage>1581</fpage>
        <lpage>1589</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.193540.115</pub-id>
        <?supplied-pmid 26355004?>
        <pub-id pub-id-type="pmid">26355004</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <mixed-citation publication-type="other">Skene PJ, Henikoff S. An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites. Elife. 2017. 10.7554/eLife.21856.</mixed-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hesselberth</surname>
            <given-names>Jay R</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Xiaoyu</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Zhihong</given-names>
          </name>
          <name>
            <surname>Sabo</surname>
            <given-names>Peter J</given-names>
          </name>
          <name>
            <surname>Sandstrom</surname>
            <given-names>Richard</given-names>
          </name>
          <name>
            <surname>Reynolds</surname>
            <given-names>Alex P</given-names>
          </name>
          <name>
            <surname>Thurman</surname>
            <given-names>Robert E</given-names>
          </name>
          <name>
            <surname>Neph</surname>
            <given-names>Shane</given-names>
          </name>
          <name>
            <surname>Kuehn</surname>
            <given-names>Michael S</given-names>
          </name>
          <name>
            <surname>Noble</surname>
            <given-names>William S</given-names>
          </name>
          <name>
            <surname>Fields</surname>
            <given-names>Stanley</given-names>
          </name>
          <name>
            <surname>Stamatoyannopoulos</surname>
            <given-names>John A</given-names>
          </name>
        </person-group>
        <article-title>Global mapping of protein-DNA interactions in vivo by digital genomic footprinting</article-title>
        <source>Nature Methods</source>
        <year>2009</year>
        <volume>6</volume>
        <issue>4</issue>
        <fpage>283</fpage>
        <lpage>289</lpage>
        <pub-id pub-id-type="doi">10.1038/nmeth.1313</pub-id>
        <?supplied-pmid 19305407?>
        <pub-id pub-id-type="pmid">19305407</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Boyle</surname>
            <given-names>AP</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>High-resolution genome-wide in vivo footprinting of diverse transcription factors in human cells</article-title>
        <source>Genome Res.</source>
        <year>2011</year>
        <volume>21</volume>
        <fpage>456</fpage>
        <lpage>464</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.112656.110</pub-id>
        <?supplied-pmid 21106903?>
        <pub-id pub-id-type="pmid">21106903</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Buenrostro</surname>
            <given-names>Jason D</given-names>
          </name>
          <name>
            <surname>Giresi</surname>
            <given-names>Paul G</given-names>
          </name>
          <name>
            <surname>Zaba</surname>
            <given-names>Lisa C</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>Howard Y</given-names>
          </name>
          <name>
            <surname>Greenleaf</surname>
            <given-names>William J</given-names>
          </name>
        </person-group>
        <article-title>Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position</article-title>
        <source>Nature Methods</source>
        <year>2013</year>
        <volume>10</volume>
        <issue>12</issue>
        <fpage>1213</fpage>
        <lpage>1218</lpage>
        <pub-id pub-id-type="doi">10.1038/nmeth.2688</pub-id>
        <?supplied-pmid 24097267?>
        <pub-id pub-id-type="pmid">24097267</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rada-Iglesias</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A unique chromatin signature uncovers early developmental enhancers in humans</article-title>
        <source>Nature</source>
        <year>2011</year>
        <volume>470</volume>
        <fpage>279</fpage>
        <lpage>283</lpage>
        <pub-id pub-id-type="doi">10.1038/nature09692</pub-id>
        <?supplied-pmid 21160473?>
        <pub-id pub-id-type="pmid">21160473</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Meyer</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>HH</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>XS</given-names>
          </name>
        </person-group>
        <article-title>BINOCh: Binding inference from nucleosome occupancy changes</article-title>
        <source>Bioinformatics</source>
        <year>2011</year>
        <volume>27</volume>
        <fpage>1867</fpage>
        <lpage>1868</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btr279</pub-id>
        <?supplied-pmid 21551136?>
        <pub-id pub-id-type="pmid">21551136</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>He</surname>
            <given-names>HH</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics</article-title>
        <source>Genome Res.</source>
        <year>2012</year>
        <volume>22</volume>
        <fpage>1015</fpage>
        <lpage>1025</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.133280.111</pub-id>
        <?supplied-pmid 22508765?>
        <pub-id pub-id-type="pmid">22508765</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Keilwagen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Posch</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Grau</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Accurate prediction of cell type-specific transcription factor binding</article-title>
        <source>Genome Biol.</source>
        <year>2019</year>
        <volume>20</volume>
        <fpage>1</fpage>
        <lpage>17</lpage>
        <pub-id pub-id-type="doi">10.1186/s13059-018-1614-y</pub-id>
        <pub-id pub-id-type="pmid">30606230</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Schreiber</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bilmes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Noble</surname>
            <given-names>WS</given-names>
          </name>
        </person-group>
        <source>Completing the ENCODE3 compendium yields accurate imputations across a variety of assays and human biosamples</source>
        <year>2019</year>
        <fpage>1</fpage>
        <lpage>20</lpage>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Qin</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Imputation for transcription factor binding predictions based on deep learning</article-title>
        <source>PLOS Comput. Biol.</source>
        <year>2017</year>
        <volume>13</volume>
        <fpage>e1005403</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pcbi.1005403</pub-id>
        <?supplied-pmid 28234893?>
        <pub-id pub-id-type="pmid">28234893</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Quang</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Guan</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <source>Anchor: trans-cell type prediction of transcription factor binding sites</source>
        <year>2019</year>
        <fpage>281</fpage>
        <lpage>292</lpage>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Karimzadeh</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hoffman</surname>
            <given-names>MM</given-names>
          </name>
        </person-group>
        <source>Virtual ChIP-seq: predicting transcription factor binding by learning from the transcriptome</source>
        <year>2018</year>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Quang</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <source>FactorNet: a deep learning framework for predicting cell type specific transcription factor binding from nucleotide-resolution sequential data</source>
        <year>2017</year>
        <fpage>1</fpage>
        <lpage>27</lpage>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Modeling cis-regulation with a compendium of genome-wide histone H3K27ac profiles</article-title>
        <source>Genome Res.</source>
        <year>2016</year>
        <volume>26</volume>
        <fpage>1417</fpage>
        <lpage>1429</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.201574.115</pub-id>
        <?supplied-pmid 27466232?>
        <pub-id pub-id-type="pmid">27466232</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Zhenjia</given-names>
          </name>
          <name>
            <surname>Civelek</surname>
            <given-names>Mete</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>Clint L</given-names>
          </name>
          <name>
            <surname>Sheffield</surname>
            <given-names>Nathan C</given-names>
          </name>
          <name>
            <surname>Guertin</surname>
            <given-names>Michael J</given-names>
          </name>
          <name>
            <surname>Zang</surname>
            <given-names>Chongzhi</given-names>
          </name>
        </person-group>
        <article-title>BART: a transcription factor prediction tool with query gene sets or epigenomic profiles</article-title>
        <source>Bioinformatics</source>
        <year>2018</year>
        <volume>34</volume>
        <issue>16</issue>
        <fpage>2867</fpage>
        <lpage>2869</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bty194</pub-id>
        <?supplied-pmid 29608647?>
        <pub-id pub-id-type="pmid">29608647</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Imrichova</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Hulselmans</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Atak</surname>
            <given-names>ZK</given-names>
          </name>
          <name>
            <surname>Potier</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Aerts</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>I-cisTarget 2015 update: generalized cis-regulatory enrichment analysis in human, mouse and fly</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2015</year>
        <volume>43</volume>
        <fpage>W57</fpage>
        <lpage>W64</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkv395</pub-id>
        <?supplied-pmid 25925574?>
        <pub-id pub-id-type="pmid">25925574</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kuleshov</surname>
            <given-names>MV</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Enrichr: a comprehensive gene set enrichment analysis web server 2016 update</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2016</year>
        <volume>44</volume>
        <fpage>W90</fpage>
        <lpage>W97</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkw377</pub-id>
        <?supplied-pmid 27141961?>
        <pub-id pub-id-type="pmid">27141961</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Long</surname>
            <given-names>HK</given-names>
          </name>
          <name>
            <surname>Prescott</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Wysocka</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Ever-changing landscapes: transcriptional enhancers in development and evolution</article-title>
        <source>Cell</source>
        <year>2016</year>
        <volume>167</volume>
        <fpage>1170</fpage>
        <lpage>1187</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2016.09.018</pub-id>
        <?supplied-pmid 27863239?>
        <pub-id pub-id-type="pmid">27863239</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Osterwalder</surname>
            <given-names>Marco</given-names>
          </name>
          <name>
            <surname>Barozzi</surname>
            <given-names>Iros</given-names>
          </name>
          <name>
            <surname>Tissières</surname>
            <given-names>Virginie</given-names>
          </name>
          <name>
            <surname>Fukuda-Yuzawa</surname>
            <given-names>Yoko</given-names>
          </name>
          <name>
            <surname>Mannion</surname>
            <given-names>Brandon J.</given-names>
          </name>
          <name>
            <surname>Afzal</surname>
            <given-names>Sarah Y.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>Elizabeth A.</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>Yiwen</given-names>
          </name>
          <name>
            <surname>Plajzer-Frick</surname>
            <given-names>Ingrid</given-names>
          </name>
          <name>
            <surname>Pickle</surname>
            <given-names>Catherine S.</given-names>
          </name>
          <name>
            <surname>Kato</surname>
            <given-names>Momoe</given-names>
          </name>
          <name>
            <surname>Garvin</surname>
            <given-names>Tyler H.</given-names>
          </name>
          <name>
            <surname>Pham</surname>
            <given-names>Quan T.</given-names>
          </name>
          <name>
            <surname>Harrington</surname>
            <given-names>Anne N.</given-names>
          </name>
          <name>
            <surname>Akiyama</surname>
            <given-names>Jennifer A.</given-names>
          </name>
          <name>
            <surname>Afzal</surname>
            <given-names>Veena</given-names>
          </name>
          <name>
            <surname>Lopez-Rios</surname>
            <given-names>Javier</given-names>
          </name>
          <name>
            <surname>Dickel</surname>
            <given-names>Diane E.</given-names>
          </name>
          <name>
            <surname>Visel</surname>
            <given-names>Axel</given-names>
          </name>
          <name>
            <surname>Pennacchio</surname>
            <given-names>Len A.</given-names>
          </name>
        </person-group>
        <article-title>Enhancer redundancy provides phenotypic robustness in mammalian development</article-title>
        <source>Nature</source>
        <year>2018</year>
        <volume>554</volume>
        <issue>7691</issue>
        <fpage>239</fpage>
        <lpage>243</lpage>
        <pub-id pub-id-type="doi">10.1038/nature25461</pub-id>
        <?supplied-pmid 29420474?>
        <pub-id pub-id-type="pmid">29420474</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fukaya</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Lim</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Levine</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Enhancer control of transcriptional bursting</article-title>
        <source>Cell</source>
        <year>2016</year>
        <volume>166</volume>
        <fpage>358</fpage>
        <lpage>368</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2016.05.025</pub-id>
        <?supplied-pmid 27293191?>
        <pub-id pub-id-type="pmid">27293191</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Ouyang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Hung</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <source>ChIP-Seq of transcription factors predicts absolute and differential gene expression in embryonic stem cells</source>
        <year>2009</year>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Target analysis by integration of transcriptome and ChIP-seq data with BETA</article-title>
        <source>Nat. Protoc.</source>
        <year>2013</year>
        <volume>8</volume>
        <fpage>2502</fpage>
        <lpage>2515</lpage>
        <pub-id pub-id-type="doi">10.1038/nprot.2013.150</pub-id>
        <?supplied-pmid 24263090?>
        <pub-id pub-id-type="pmid">24263090</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sikora-Wohlfeld</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Ackermann</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Christodoulou</surname>
            <given-names>EG</given-names>
          </name>
          <name>
            <surname>Singaravelu</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Beyer</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Assessing computational methods for transcription factor target gene identification based on ChIP-seq data</article-title>
        <source>PLoS Comput. Biol.</source>
        <year>2013</year>
        <volume>9</volume>
        <fpage>e1003342</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pcbi.1003342</pub-id>
        <?supplied-pmid 24278002?>
        <pub-id pub-id-type="pmid">24278002</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <source>Cauchy combination test: a powerful test with analytic p-value calculation under arbitrary dependency structures</source>
        <year>2018</year>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chia</surname>
            <given-names>Na-Yu</given-names>
          </name>
          <name>
            <surname>Deng</surname>
            <given-names>Niantao</given-names>
          </name>
          <name>
            <surname>Das</surname>
            <given-names>Kakoli</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>Dachuan</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>Longyu</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>Yansong</given-names>
          </name>
          <name>
            <surname>Lim</surname>
            <given-names>Kiat Hon</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>Ming-Hui</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>Jeanie</given-names>
          </name>
          <name>
            <surname>Sam</surname>
            <given-names>Xin Xiu</given-names>
          </name>
          <name>
            <surname>Tan</surname>
            <given-names>Gek San</given-names>
          </name>
          <name>
            <surname>Wan</surname>
            <given-names>Wei Keat</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>Willie</given-names>
          </name>
          <name>
            <surname>Gan</surname>
            <given-names>Anna</given-names>
          </name>
          <name>
            <surname>Tan</surname>
            <given-names>Angie Lay Keng</given-names>
          </name>
          <name>
            <surname>Tay</surname>
            <given-names>Su-Ting</given-names>
          </name>
          <name>
            <surname>Soo</surname>
            <given-names>Khee Chee</given-names>
          </name>
          <name>
            <surname>Wong</surname>
            <given-names>Wai Keong</given-names>
          </name>
          <name>
            <surname>Dominguez</surname>
            <given-names>Lourdes Trinidad M</given-names>
          </name>
          <name>
            <surname>Ng</surname>
            <given-names>Huck-Hui</given-names>
          </name>
          <name>
            <surname>Rozen</surname>
            <given-names>Steve</given-names>
          </name>
          <name>
            <surname>Goh</surname>
            <given-names>Liang-Kee</given-names>
          </name>
          <name>
            <surname>Teh</surname>
            <given-names>Bin-Tean</given-names>
          </name>
          <name>
            <surname>Tan</surname>
            <given-names>Patrick</given-names>
          </name>
        </person-group>
        <article-title>Regulatory crosstalk between lineage-survival oncogenesKLF5, GATA4andGATA6cooperatively promotes gastric cancer development</article-title>
        <source>Gut</source>
        <year>2014</year>
        <volume>64</volume>
        <issue>5</issue>
        <fpage>707</fpage>
        <lpage>719</lpage>
        <pub-id pub-id-type="doi">10.1136/gutjnl-2013-306596</pub-id>
        <?supplied-pmid 25053715?>
        <pub-id pub-id-type="pmid">25053715</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <mixed-citation publication-type="other">Yang XZ, et al. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway. Mol. Cancer. 2018. 10.1186/s12943-018-0874-1.</mixed-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hwang</surname>
            <given-names>JTK</given-names>
          </name>
          <name>
            <surname>Kelly</surname>
            <given-names>GM</given-names>
          </name>
        </person-group>
        <article-title>GATA6 and FOXA2 regulate Wnt6 expression during extraembryonic endoderm formation</article-title>
        <source>Stem Cells Dev.</source>
        <year>2012</year>
        <volume>21</volume>
        <fpage>3220</fpage>
        <lpage>3232</lpage>
        <pub-id pub-id-type="doi">10.1089/scd.2011.0492</pub-id>
        <?supplied-pmid 22607194?>
        <pub-id pub-id-type="pmid">22607194</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Weidenfeld</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Shu</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Millar</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>Morrisey</surname>
            <given-names>EE</given-names>
          </name>
        </person-group>
        <article-title>The WNT7b promoter is regulated by TTF-1, GATA6, and Foxa2 in lung epithelium</article-title>
        <source>J. Biol. Chem.</source>
        <year>2002</year>
        <volume>277</volume>
        <fpage>21061</fpage>
        <lpage>21070</lpage>
        <pub-id pub-id-type="doi">10.1074/jbc.M111702200</pub-id>
        <?supplied-pmid 11914369?>
        <pub-id pub-id-type="pmid">11914369</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Muzikar</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>Nickols</surname>
            <given-names>NG</given-names>
          </name>
          <name>
            <surname>Dervan</surname>
            <given-names>PB</given-names>
          </name>
        </person-group>
        <source>Repression of DNA-binding dependent glucocorticoid receptor-mediated gene expression</source>
        <year>2009</year>
        <fpage>2009</fpage>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Alvarez</surname>
            <given-names>Mariano J</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>Yao</given-names>
          </name>
          <name>
            <surname>Giorgi</surname>
            <given-names>Federico M</given-names>
          </name>
          <name>
            <surname>Lachmann</surname>
            <given-names>Alexander</given-names>
          </name>
          <name>
            <surname>Ding</surname>
            <given-names>B Belinda</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>B Hilda</given-names>
          </name>
          <name>
            <surname>Califano</surname>
            <given-names>Andrea</given-names>
          </name>
        </person-group>
        <article-title>Functional characterization of somatic mutations in cancer using network-based inference of protein activity</article-title>
        <source>Nature Genetics</source>
        <year>2016</year>
        <volume>48</volume>
        <issue>8</issue>
        <fpage>838</fpage>
        <lpage>847</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.3593</pub-id>
        <?supplied-pmid 27322546?>
        <pub-id pub-id-type="pmid">27322546</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fiaschetti</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Castelletti</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Zoller</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Schramm</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Schroeder</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Nagaishi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Stearns</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Mittelbronn</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Eggert</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Westermann</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Ohgaki</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Shalaby</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Pruschy</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Arcaro</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Grotzer</surname>
            <given-names>M A</given-names>
          </name>
        </person-group>
        <article-title>Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma</article-title>
        <source>Oncogene</source>
        <year>2011</year>
        <volume>30</volume>
        <issue>25</issue>
        <fpage>2823</fpage>
        <lpage>2835</lpage>
        <pub-id pub-id-type="doi">10.1038/onc.2011.10</pub-id>
        <?supplied-pmid 21317922?>
        <pub-id pub-id-type="pmid">21317922</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vencken</surname>
            <given-names>Sebastian F</given-names>
          </name>
          <name>
            <surname>Sethupathy</surname>
            <given-names>Praveen</given-names>
          </name>
          <name>
            <surname>Blackshields</surname>
            <given-names>Gordon</given-names>
          </name>
          <name>
            <surname>Spillane</surname>
            <given-names>Cathy</given-names>
          </name>
          <name>
            <surname>Elbaruni</surname>
            <given-names>Salah</given-names>
          </name>
          <name>
            <surname>Sheils</surname>
            <given-names>Orla</given-names>
          </name>
          <name>
            <surname>Gallagher</surname>
            <given-names>Michael F</given-names>
          </name>
          <name>
            <surname>O’Leary</surname>
            <given-names>John J</given-names>
          </name>
        </person-group>
        <article-title>An integrated analysis of the SOX2 microRNA response program in human pluripotent and nullipotent stem cell lines</article-title>
        <source>BMC Genomics</source>
        <year>2014</year>
        <volume>15</volume>
        <issue>1</issue>
        <fpage>711</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2164-15-711</pub-id>
        <?supplied-pmid 25156079?>
        <pub-id pub-id-type="pmid">25156079</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ci</surname>
            <given-names>Weimin</given-names>
          </name>
          <name>
            <surname>Polo</surname>
            <given-names>Jose M.</given-names>
          </name>
          <name>
            <surname>Cerchietti</surname>
            <given-names>Leandro</given-names>
          </name>
          <name>
            <surname>Shaknovich</surname>
            <given-names>Rita</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Ling</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Shao Ning</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>Kenny</given-names>
          </name>
          <name>
            <surname>Farinha</surname>
            <given-names>Pedro</given-names>
          </name>
          <name>
            <surname>Horsman</surname>
            <given-names>Douglas E.</given-names>
          </name>
          <name>
            <surname>Gascoyne</surname>
            <given-names>Randy D.</given-names>
          </name>
          <name>
            <surname>Elemento</surname>
            <given-names>Olivier</given-names>
          </name>
          <name>
            <surname>Melnick</surname>
            <given-names>Ari</given-names>
          </name>
        </person-group>
        <article-title>The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL</article-title>
        <source>Blood</source>
        <year>2009</year>
        <volume>113</volume>
        <issue>22</issue>
        <fpage>5536</fpage>
        <lpage>5548</lpage>
        <pub-id pub-id-type="doi">10.1182/blood-2008-12-193037</pub-id>
        <?supplied-pmid 19307668?>
        <pub-id pub-id-type="pmid">19307668</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Parekh</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms</article-title>
        <source>Blood</source>
        <year>2007</year>
        <volume>110</volume>
        <fpage>2067</fpage>
        <lpage>2074</lpage>
        <pub-id pub-id-type="doi">10.1182/blood-2007-01-069575</pub-id>
        <?supplied-pmid 17545502?>
        <pub-id pub-id-type="pmid">17545502</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huynh</surname>
            <given-names>KD</given-names>
          </name>
          <name>
            <surname>Bardwell</surname>
            <given-names>VJ</given-names>
          </name>
        </person-group>
        <article-title>The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT</article-title>
        <source>Oncogene</source>
        <year>1998</year>
        <volume>17</volume>
        <fpage>2473</fpage>
        <lpage>2484</lpage>
        <pub-id pub-id-type="doi">10.1038/sj.onc.1202197</pub-id>
        <?supplied-pmid 9824158?>
        <pub-id pub-id-type="pmid">9824158</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cui</surname>
            <given-names>Jiajun</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Yutao</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Chuanfu</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>Pinliang</given-names>
          </name>
          <name>
            <surname>Kan</surname>
            <given-names>Wei</given-names>
          </name>
          <name>
            <surname>Bai</surname>
            <given-names>Xianhong</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Xuelin</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>Hongbin</given-names>
          </name>
        </person-group>
        <article-title>FBI-1 functions as a novel AR co-repressor in prostate cancer cells</article-title>
        <source>Cellular and Molecular Life Sciences</source>
        <year>2010</year>
        <volume>68</volume>
        <issue>6</issue>
        <fpage>1091</fpage>
        <lpage>1103</lpage>
        <pub-id pub-id-type="doi">10.1007/s00018-010-0511-7</pub-id>
        <?supplied-pmid 20812024?>
        <pub-id pub-id-type="pmid">20812024</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <mixed-citation publication-type="other">Wei, F., Zaprazna, K., Wang, J. &amp; Atchison, M. L. PU.1 Can Recruit BCL6 to DNA to repress gene expression in germinal center B cells. Mol. Cell. Biol. 29, 4612–4622 (2009).</mixed-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Doerr</surname>
            <given-names>Audrey</given-names>
          </name>
        </person-group>
        <article-title>Atelier sur la recherche en administration publique au Canada</article-title>
        <source>Canadian Public Administration/Administration publique du Canada</source>
        <year>1984</year>
        <volume>27</volume>
        <issue>4</issue>
        <fpage>660</fpage>
        <lpage>677</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1754-7121.1984.tb00653.x</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Grandori</surname>
            <given-names>Carla</given-names>
          </name>
          <name>
            <surname>Cowley</surname>
            <given-names>Shaun M.</given-names>
          </name>
          <name>
            <surname>James</surname>
            <given-names>Leonard P.</given-names>
          </name>
          <name>
            <surname>Eisenman</surname>
            <given-names>Robert N.</given-names>
          </name>
        </person-group>
        <article-title>The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior</article-title>
        <source>Annual Review of Cell and Developmental Biology</source>
        <year>2000</year>
        <volume>16</volume>
        <issue>1</issue>
        <fpage>653</fpage>
        <lpage>699</lpage>
        <pub-id pub-id-type="doi">10.1146/annurev.cellbio.16.1.653</pub-id>
        <?supplied-pmid 11031250?>
        <pub-id pub-id-type="pmid">11031250</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <mixed-citation publication-type="other">Tzatsos A, et al. KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs. J. Clin. Invest. 2013. 10.1172/JCI64535.</mixed-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Andoniadou</surname>
            <given-names>CL</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Sox2+stem/progenitor cells in the adult mouse pituitary support organ homeostasis and have tumor-inducing potential</article-title>
        <source>Cell Stem Cell</source>
        <year>2013</year>
        <volume>13</volume>
        <fpage>433</fpage>
        <lpage>445</lpage>
        <pub-id pub-id-type="doi">10.1016/j.stem.2013.07.004</pub-id>
        <?supplied-pmid 24094324?>
        <pub-id pub-id-type="pmid">24094324</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Friedman</surname>
            <given-names>J. R.</given-names>
          </name>
          <name>
            <surname>Kaestner</surname>
            <given-names>K. H.</given-names>
          </name>
        </person-group>
        <article-title>The Foxa family of transcription factors in development and metabolism</article-title>
        <source>Cellular and Molecular Life Sciences</source>
        <year>2006</year>
        <volume>63</volume>
        <issue>19-20</issue>
        <fpage>2317</fpage>
        <lpage>2328</lpage>
        <pub-id pub-id-type="doi">10.1007/s00018-006-6095-6</pub-id>
        <?supplied-pmid 16909212?>
        <pub-id pub-id-type="pmid">16909212</pub-id>
      </element-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <source>Foxa1 contributes to the repression of Nanog expression by recruiting Grg3 during the differentiation of pluripotent P19 embryonal carcinoma cells</source>
        <year>2014</year>
        <fpage>6</fpage>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hagey</surname>
            <given-names>Daniel W.</given-names>
          </name>
          <name>
            <surname>Klum</surname>
            <given-names>Susanne</given-names>
          </name>
          <name>
            <surname>Kurtsdotter</surname>
            <given-names>Idha</given-names>
          </name>
          <name>
            <surname>Zaouter</surname>
            <given-names>Cecile</given-names>
          </name>
          <name>
            <surname>Topcic</surname>
            <given-names>Danijal</given-names>
          </name>
          <name>
            <surname>Andersson</surname>
            <given-names>Olov</given-names>
          </name>
          <name>
            <surname>Bergsland</surname>
            <given-names>Maria</given-names>
          </name>
          <name>
            <surname>Muhr</surname>
            <given-names>Jonas</given-names>
          </name>
        </person-group>
        <article-title>SOX2 regulates common and specific stem cell features in the CNS and endoderm derived organs</article-title>
        <source>PLOS Genetics</source>
        <year>2018</year>
        <volume>14</volume>
        <issue>2</issue>
        <fpage>e1007224</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pgen.1007224</pub-id>
        <?supplied-pmid 29432416?>
        <pub-id pub-id-type="pmid">29432416</pub-id>
      </element-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Teo</surname>
            <given-names>A. K. K.</given-names>
          </name>
          <name>
            <surname>Arnold</surname>
            <given-names>S. J.</given-names>
          </name>
          <name>
            <surname>Trotter</surname>
            <given-names>M. W. B.</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Ang</surname>
            <given-names>L. T.</given-names>
          </name>
          <name>
            <surname>Chng</surname>
            <given-names>Z.</given-names>
          </name>
          <name>
            <surname>Robertson</surname>
            <given-names>E. J.</given-names>
          </name>
          <name>
            <surname>Dunn</surname>
            <given-names>N. R.</given-names>
          </name>
          <name>
            <surname>Vallier</surname>
            <given-names>L.</given-names>
          </name>
        </person-group>
        <article-title>Pluripotency factors regulate definitive endoderm specification through eomesodermin</article-title>
        <source>Genes &amp; Development</source>
        <year>2011</year>
        <volume>25</volume>
        <issue>3</issue>
        <fpage>238</fpage>
        <lpage>250</lpage>
        <pub-id pub-id-type="doi">10.1101/gad.607311</pub-id>
        <pub-id pub-id-type="pmid">21245162</pub-id>
      </element-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Segal</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Module networks: identify regulatory modules and their condition-specific regulators from gene expression data</article-title>
        <source>Nat. Genet.</source>
        <year>2003</year>
        <volume>34</volume>
        <fpage>166</fpage>
        <lpage>176</lpage>
        <pub-id pub-id-type="doi">10.1038/ng1165</pub-id>
        <?supplied-pmid 12740579?>
        <pub-id pub-id-type="pmid">12740579</pub-id>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Carroll</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Prall</surname>
            <given-names>OWJ</given-names>
          </name>
          <name>
            <surname>Musgrove</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Sutherland</surname>
            <given-names>RL</given-names>
          </name>
        </person-group>
        <article-title>A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence</article-title>
        <source>J. Biol. Chem.</source>
        <year>2000</year>
        <volume>275</volume>
        <fpage>38221</fpage>
        <lpage>38229</lpage>
        <pub-id pub-id-type="doi">10.1074/jbc.M004424200</pub-id>
        <?supplied-pmid 10991938?>
        <pub-id pub-id-type="pmid">10991938</pub-id>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Daofeng</given-names>
          </name>
          <name>
            <surname>Hsu</surname>
            <given-names>Silas</given-names>
          </name>
          <name>
            <surname>Purushotham</surname>
            <given-names>Deepak</given-names>
          </name>
          <name>
            <surname>Sears</surname>
            <given-names>Renee L</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Ting</given-names>
          </name>
        </person-group>
        <article-title>WashU Epigenome Browser update 2019</article-title>
        <source>Nucleic Acids Research</source>
        <year>2019</year>
        <volume>47</volume>
        <issue>W1</issue>
        <fpage>W158</fpage>
        <lpage>W165</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkz348</pub-id>
        <?supplied-pmid 31165883?>
        <pub-id pub-id-type="pmid">31165883</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>DiRenzo</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lazar</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Cofactor Dynamics and sufficiency in estrogen receptor–regulated transcription</article-title>
        <source>Cell</source>
        <year>2000</year>
        <volume>103</volume>
        <fpage>843</fpage>
        <lpage>852</lpage>
        <pub-id pub-id-type="doi">10.1016/S0092-8674(00)00188-4</pub-id>
        <?supplied-pmid 11136970?>
        <pub-id pub-id-type="pmid">11136970</pub-id>
      </element-citation>
    </ref>
    <ref id="CR64">
      <label>64.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vockley</surname>
            <given-names>CM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Direct GR binding sites potentiate clusters of TF binding across the human genome</article-title>
        <source>Cell</source>
        <year>2016</year>
        <volume>166</volume>
        <fpage>1269</fpage>
        <lpage>1281</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2016.07.049</pub-id>
        <?supplied-pmid 27565349?>
        <pub-id pub-id-type="pmid">27565349</pub-id>
      </element-citation>
    </ref>
    <ref id="CR65">
      <label>65.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Crow</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lim</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Ballouz</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Pavlidis</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Gillis</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Predictability of human differential gene expression</article-title>
        <source>Proc. Natl. Acad. Sci. U. S. A.</source>
        <year>2019</year>
        <volume>116</volume>
        <fpage>6491</fpage>
        <lpage>6500</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1802973116</pub-id>
        <?supplied-pmid 30846554?>
        <pub-id pub-id-type="pmid">30846554</pub-id>
      </element-citation>
    </ref>
    <ref id="CR66">
      <label>66.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Muhar</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis</article-title>
        <source>Science (80-. )</source>
        <year>2018</year>
        <volume>360</volume>
        <fpage>800</fpage>
        <lpage>805</lpage>
        <pub-id pub-id-type="doi">10.1126/science.aao2793</pub-id>
      </element-citation>
    </ref>
    <ref id="CR67">
      <label>67.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Aibar</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <source>SCENIC: single-cell regulatory network inference and clustering</source>
        <year>2017</year>
        <fpage>14</fpage>
      </element-citation>
    </ref>
    <ref id="CR68">
      <label>68.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kent</surname>
            <given-names>W. J.</given-names>
          </name>
          <name>
            <surname>Zweig</surname>
            <given-names>A. S.</given-names>
          </name>
          <name>
            <surname>Barber</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Hinrichs</surname>
            <given-names>A. S.</given-names>
          </name>
          <name>
            <surname>Karolchik</surname>
            <given-names>D.</given-names>
          </name>
        </person-group>
        <article-title>BigWig and BigBed: enabling browsing of large distributed datasets</article-title>
        <source>Bioinformatics</source>
        <year>2010</year>
        <volume>26</volume>
        <issue>17</issue>
        <fpage>2204</fpage>
        <lpage>2207</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btq351</pub-id>
        <?supplied-pmid 20639541?>
        <pub-id pub-id-type="pmid">20639541</pub-id>
      </element-citation>
    </ref>
    <ref id="CR69">
      <label>69.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Matys</surname>
            <given-names>V</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>TRANSFAC®: transcriptional regulation, from patterns to profiles</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2003</year>
        <volume>31</volume>
        <fpage>374</fpage>
        <lpage>378</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkg108</pub-id>
        <?supplied-pmid 12520026?>
        <pub-id pub-id-type="pmid">12520026</pub-id>
      </element-citation>
    </ref>
    <ref id="CR70">
      <label>70.</label>
      <mixed-citation publication-type="other">Mathelier A. et al. JASPAR 2016: a major expansion and update of the open-access database of transcription factor binding. Nucleic Acids Res. 2016;44(D1):110–5.</mixed-citation>
    </ref>
    <ref id="CR71">
      <label>71.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Cistrome: an integrative platform for transcriptional regulation studies</article-title>
        <source>Genome Biol.</source>
        <year>2011</year>
        <volume>12</volume>
        <fpage>R83</fpage>
        <pub-id pub-id-type="doi">10.1186/gb-2011-12-8-r83</pub-id>
        <?supplied-pmid 21859476?>
        <pub-id pub-id-type="pmid">21859476</pub-id>
      </element-citation>
    </ref>
    <ref id="CR72">
      <label>72.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Quinlan</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Hall</surname>
            <given-names>IM</given-names>
          </name>
        </person-group>
        <article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title>
        <source>Bioinformatics</source>
        <year>2010</year>
        <volume>26</volume>
        <fpage>841</fpage>
        <lpage>842</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btq033</pub-id>
        <?supplied-pmid 20110278?>
        <pub-id pub-id-type="pmid">20110278</pub-id>
      </element-citation>
    </ref>
    <ref id="CR73">
      <label>73.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Köster</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Rahmann</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Snakemake--a scalable bioinformatics workflow engine</article-title>
        <source>Bioinformatics</source>
        <year>2012</year>
        <volume>28</volume>
        <fpage>2520</fpage>
        <lpage>2522</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bts480</pub-id>
        <?supplied-pmid 22908215?>
        <pub-id pub-id-type="pmid">22908215</pub-id>
      </element-citation>
    </ref>
    <ref id="CR74">
      <label>74.</label>
      <mixed-citation publication-type="other">Qin Q, et al. Lisa: inferring transcriptional regulators through integrative modeling of public chromatin accessibility and ChIP-seq data. Github. 2019; <ext-link ext-link-type="uri" xlink:href="https://github.com/liulab-dfci/lisa">https://github.com/liulab-dfci/lisa</ext-link>.</mixed-citation>
    </ref>
    <ref id="CR75">
      <label>75.</label>
      <mixed-citation publication-type="other">Qin Q, et al. Lisa: inferring transcriptional regulators through integrative modeling of public chromatin accessibility and ChIP-seq data. Zenodo. 2019; <ext-link ext-link-type="uri" xlink:href="https://zenodo.org/record/3583466#.XhjmQlVKhaQ">https://zenodo.org/record/3583466#.XhjmQlVKhaQ</ext-link>.</mixed-citation>
    </ref>
  </ref-list>
</back>
